These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ý
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Maryland
|
|
26-2749336
|
|
(State or Other Jurisdiction of
Incorporation or Organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
|
1555 Peachtree Street, N.E., Suite 1800
Atlanta, Georgia
|
|
30309
|
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
|
Large Accelerated filer
|
|
ý
|
|
|
Accelerated filer
|
|
o
|
|
Non-Accelerated filer
|
|
o
|
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
|
o
|
|
|
|
|
|
|
Emerging growth company
|
|
o
|
|
|
|
Page
|
|
|
|
|
|
Item 1.
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
Item 2.
|
||
|
|
|
|
|
Item 3.
|
||
|
|
|
|
|
Item 4.
|
||
|
|
|
|
|
|
|
|
|
Item 1.
|
||
|
|
|
|
|
Item 1A.
|
||
|
|
|
|
|
Item 2.
|
||
|
|
|
|
|
Item 3.
|
||
|
|
|
|
|
Item 4.
|
||
|
|
|
|
|
Item 5.
|
||
|
|
|
|
|
Item 6.
|
||
|
ITEM 1.
|
FINANCIAL STATEMENTS
|
|
|
As of
|
||||
|
$ in thousands except share amounts
|
March 31, 2017
|
|
December 31, 2016
|
||
|
ASSETS
|
|
||||
|
Mortgage-backed and credit risk transfer securities, at fair value (including pledged securities of $15,562,355 and $14,422,198, respectively)
|
15,921,097
|
|
|
14,981,331
|
|
|
Commercial loans, held-for-investment
|
275,944
|
|
|
273,355
|
|
|
Cash and cash equivalents
|
55,877
|
|
|
161,788
|
|
|
Due from counterparties
|
—
|
|
|
86,450
|
|
|
Investment related receivable
|
285,910
|
|
|
43,886
|
|
|
Accrued interest receivable
|
49,703
|
|
|
46,945
|
|
|
Derivative assets, at fair value
|
5,799
|
|
|
3,186
|
|
|
Other assets
|
112,957
|
|
|
109,297
|
|
|
Total assets
|
16,707,287
|
|
|
15,706,238
|
|
|
LIABILITIES AND EQUITY
|
|
|
|
||
|
Liabilities:
|
|
|
|
||
|
Repurchase agreements
|
12,289,899
|
|
|
11,160,669
|
|
|
Secured loans
|
1,650,000
|
|
|
1,650,000
|
|
|
Exchangeable senior notes
|
248,530
|
|
|
397,041
|
|
|
Derivative liabilities, at fair value
|
45,623
|
|
|
134,228
|
|
|
Dividends and distributions payable
|
50,928
|
|
|
50,924
|
|
|
Investment related payable
|
72,572
|
|
|
9,232
|
|
|
Accrued interest payable
|
11,206
|
|
|
21,066
|
|
|
Collateral held payable
|
3,732
|
|
|
1,700
|
|
|
Accounts payable and accrued expenses
|
1,821
|
|
|
1,534
|
|
|
Due to affiliate
|
9,346
|
|
|
9,660
|
|
|
Total liabilities
|
14,383,657
|
|
|
13,436,054
|
|
|
Commitments and contingencies (See Note 16):
|
|
|
|
||
|
Equity:
|
|
|
|
||
|
Preferred Stock, par value $0.01 per share; 50,000,000 shares authorized:
|
|
|
|
||
|
7.75% Series A Cumulative Redeemable Preferred Stock: 5,600,000 shares issued and outstanding ($140,000 aggregate liquidation preference)
|
135,356
|
|
|
135,356
|
|
|
7.75% Fixed-to-Floating Series B Cumulative Redeemable Preferred Stock: 6,200,000 shares issued and outstanding ($155,000 aggregate liquidation preference)
|
149,860
|
|
|
149,860
|
|
|
Common Stock, par value $0.01 per share; 450,000,000 shares authorized; 111,604,609 and 111,594,595 shares issued and outstanding, respectively
|
1,116
|
|
|
1,116
|
|
|
Additional paid in capital
|
2,380,053
|
|
|
2,379,863
|
|
|
Accumulated other comprehensive income
|
303,765
|
|
|
293,668
|
|
|
Retained earnings (distributions in excess of earnings)
|
(675,815
|
)
|
|
(718,303
|
)
|
|
Total stockholders’ equity
|
2,294,335
|
|
|
2,241,560
|
|
|
Non-controlling interest
|
29,295
|
|
|
28,624
|
|
|
Total equity
|
2,323,630
|
|
|
2,270,184
|
|
|
Total liabilities and equity
|
16,707,287
|
|
|
15,706,238
|
|
|
|
1
|
|
|
|
Three Months Ended
March 31, |
||||
|
$ in thousands, except share amounts
|
2017
|
|
2016
|
||
|
Interest Income
|
|
|
|
||
|
Mortgage-backed and credit risk transfer securities
|
118,873
|
|
|
122,246
|
|
|
Commercial loans
|
5,764
|
|
|
4,893
|
|
|
Total interest income
|
124,637
|
|
|
127,139
|
|
|
Interest Expense
|
|
|
|
||
|
Repurchase agreements
|
29,947
|
|
|
41,800
|
|
|
Secured loans
|
3,413
|
|
|
2,715
|
|
|
Exchangeable senior notes
|
5,008
|
|
|
5,613
|
|
|
Total interest expense
|
38,368
|
|
|
50,128
|
|
|
Net interest income
|
86,269
|
|
|
77,011
|
|
|
Other Income (loss)
|
|
|
|
||
|
Gain (loss) on investments, net
|
(1,853
|
)
|
|
11,601
|
|
|
Equity in earnings (losses) of unconsolidated ventures
|
(1,534
|
)
|
|
1,061
|
|
|
Gain (loss) on derivative instruments, net
|
5,462
|
|
|
(238,543
|
)
|
|
Realized and unrealized credit derivative income (loss), net
|
19,955
|
|
|
8,410
|
|
|
Net loss on extinguishment of debt
|
(4,711
|
)
|
|
—
|
|
|
Other investment income (loss), net
|
1,329
|
|
|
(318
|
)
|
|
Total other income (loss)
|
18,648
|
|
|
(217,789
|
)
|
|
Expenses
|
|
|
|
||
|
Management fee – related party
|
8,801
|
|
|
9,512
|
|
|
General and administrative
|
2,084
|
|
|
2,037
|
|
|
Total expenses
|
10,885
|
|
|
11,549
|
|
|
Net income (loss)
|
94,032
|
|
|
(152,327
|
)
|
|
Net income (loss) attributable to non-controlling interest
|
1,186
|
|
|
(1,883
|
)
|
|
Net income (loss) attributable to Invesco Mortgage Capital Inc.
|
92,846
|
|
|
(150,444
|
)
|
|
Dividends to preferred stockholders
|
5,716
|
|
|
5,716
|
|
|
Net income (loss) attributable to common stockholders
|
87,130
|
|
|
(156,160
|
)
|
|
Earnings (loss) per share:
|
|
|
|
|
|
|
Net income (loss) attributable to common stockholders
|
|
|
|
||
|
Basic
|
0.78
|
|
|
(1.38
|
)
|
|
Diluted
|
0.73
|
|
|
(1.38
|
)
|
|
Dividends declared per common share
|
0.40
|
|
|
0.40
|
|
|
|
2
|
|
|
|
Three Months Ended
March 31, |
||||
|
$ in thousands
|
2017
|
|
2016
|
||
|
Net income (loss)
|
94,032
|
|
|
(152,327
|
)
|
|
Other comprehensive income (loss):
|
|
|
|
||
|
Unrealized gain (loss) on mortgage-backed and credit risk transfer securities, net
|
16,289
|
|
|
121,460
|
|
|
Reclassification of unrealized (gain) loss on sale of mortgage-backed and credit risk transfer securities to gain (loss) on investments, net
|
850
|
|
|
(10,544
|
)
|
|
Reclassification of amortization of net deferred (gain) loss on de-designated interest rate swaps to repurchase agreements interest expense
|
(6,298
|
)
|
|
12,924
|
|
|
Currency translation adjustments on investment in unconsolidated venture
|
(615
|
)
|
|
(49
|
)
|
|
Total other comprehensive income (loss)
|
10,226
|
|
|
123,791
|
|
|
Comprehensive income (loss)
|
104,258
|
|
|
(28,536
|
)
|
|
Less: Comprehensive income (loss) attributable to non-controlling interest
|
(1,315
|
)
|
|
341
|
|
|
Less: Dividends to preferred stockholders
|
(5,716
|
)
|
|
(5,716
|
)
|
|
Comprehensive income (loss) attributable to common stockholders
|
97,227
|
|
|
(33,911
|
)
|
|
|
3
|
|
|
|
|
|
|
|
|
Attributable to Common Stockholders
|
|
|
|
|
|||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
Additional
Paid in
Capital
|
|
Accumulated
Other
Comprehensive
Income
|
|
Retained
Earnings
(Distributions
in excess of
earnings)
|
|
Total
Stockholders’ Equity |
|
Non-
Controlling
Interest
|
|
|
||||||||||||||||
|
|
Series A
Preferred Stock
|
|
Series B
Preferred Stock
|
|
|
|
|
||||||||||||||||||||||||||||
|
$ in thousands except
share amounts
|
|
|
Common Stock
|
|
Total
Equity
|
||||||||||||||||||||||||||||||
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
|
|
|
|
|
|||||||||||||||||||
|
Balance at December 31, 2016
|
5,600,000
|
|
|
135,356
|
|
|
6,200,000
|
|
|
149,860
|
|
|
111,594,595
|
|
|
1,116
|
|
|
2,379,863
|
|
|
293,668
|
|
|
(718,303
|
)
|
|
2,241,560
|
|
|
28,624
|
|
|
2,270,184
|
|
|
Net income (loss)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
92,846
|
|
|
92,846
|
|
|
1,186
|
|
|
94,032
|
|
|
Other comprehensive income (loss)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
10,097
|
|
|
—
|
|
|
10,097
|
|
|
129
|
|
|
10,226
|
|
|
Stock awards
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
10,014
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Common stock dividends
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(44,642
|
)
|
|
(44,642
|
)
|
|
—
|
|
|
(44,642
|
)
|
|
Common unit dividends
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(570
|
)
|
|
(570
|
)
|
|
Preferred stock dividends
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(5,716
|
)
|
|
(5,716
|
)
|
|
—
|
|
|
(5,716
|
)
|
|
Amortization of equity-based compensation
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
115
|
|
|
—
|
|
|
—
|
|
|
115
|
|
|
1
|
|
|
116
|
|
|
Rebalancing of ownership percentage of non-controlling interest
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
75
|
|
|
—
|
|
|
—
|
|
|
75
|
|
|
(75
|
)
|
|
—
|
|
|
Balance at March 31, 2017
|
5,600,000
|
|
|
135,356
|
|
|
6,200,000
|
|
|
149,860
|
|
|
111,604,609
|
|
|
1,116
|
|
|
2,380,053
|
|
|
303,765
|
|
|
(675,815
|
)
|
|
2,294,335
|
|
|
29,295
|
|
|
2,323,630
|
|
|
|
4
|
|
|
|
Three Months Ended March 31,
|
||||
|
$ in thousands
|
2017
|
|
2016
|
||
|
Cash Flows from Operating Activities
|
|
|
|
||
|
Net income (loss)
|
94,032
|
|
|
(152,327
|
)
|
|
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
|
|
|
|
||
|
Amortization of mortgage-backed and credit risk transfer securities premiums and (discounts), net
|
27,196
|
|
|
24,048
|
|
|
Amortization of commercial loan origination fees
|
(82
|
)
|
|
(59
|
)
|
|
Unrealized (gain) loss on derivative instruments, net
|
(13,438
|
)
|
|
166,467
|
|
|
Unrealized (gain) loss on credit derivatives, net
|
(14,148
|
)
|
|
(3,016
|
)
|
|
(Gain) loss on investments, net
|
1,853
|
|
|
(11,601
|
)
|
|
Realized (gain) loss on derivative instruments, net
|
(14,918
|
)
|
|
42,985
|
|
|
Realized (gain) loss on credit derivatives, net
|
—
|
|
|
920
|
|
|
Equity in (earnings) losses of unconsolidated ventures
|
1,534
|
|
|
(1,061
|
)
|
|
Amortization of equity-based compensation
|
116
|
|
|
117
|
|
|
Amortization of deferred securitization and financing costs
|
528
|
|
|
614
|
|
|
Amortization of net deferred losses on de-designated interest rate swaps
|
(6,298
|
)
|
|
12,924
|
|
|
Net loss on extinguishment of debt
|
4,711
|
|
|
—
|
|
|
(Gain) loss on foreign currency transactions, net
|
(513
|
)
|
|
1,125
|
|
|
Changes in operating assets and liabilities:
|
|
|
|
||
|
(Increase) decrease in operating assets
|
(2,618
|
)
|
|
2,249
|
|
|
Decrease in operating liabilities
|
(7,103
|
)
|
|
(4,527
|
)
|
|
Net cash provided by operating activities
|
70,852
|
|
|
78,858
|
|
|
Cash Flows from Investing Activities
|
|
|
|
||
|
Purchase of mortgage-backed and credit risk transfer securities
|
(1,846,444
|
)
|
|
(47,716
|
)
|
|
(Contributions to) distributions from investment in unconsolidated ventures, net
|
(2,410
|
)
|
|
(116
|
)
|
|
Purchase of exchange-traded fund
|
(3,508
|
)
|
|
—
|
|
|
Principal payments from mortgage-backed and credit risk transfer securities
|
553,882
|
|
|
528,138
|
|
|
Proceeds from sale of mortgage-backed and credit risk transfer securities
|
180,809
|
|
|
684,345
|
|
|
Payments on sale of credit derivatives
|
—
|
|
|
(920
|
)
|
|
Proceeds from/ (payments for) settlement or termination of forwards, swaps and swaptions, net
|
14,918
|
|
|
(37,228
|
)
|
|
Origination and advances of commercial loans, net of origination fees
|
(2,014
|
)
|
|
(69,830
|
)
|
|
Net cash provided by (used in) investing activities
|
(1,104,767
|
)
|
|
1,056,673
|
|
|
Cash Flows from Financing Activities
|
|
|
|
||
|
Proceeds from issuance of common stock
|
—
|
|
|
35
|
|
|
Repurchase of common stock
|
—
|
|
|
(25,000
|
)
|
|
Due from counterparties
|
—
|
|
|
(116,766
|
)
|
|
Change in collateral held payable
|
2,032
|
|
|
(4,900
|
)
|
|
Proceeds from repurchase agreements
|
30,147,699
|
|
|
29,578,250
|
|
|
Principal repayments of repurchase agreements
|
(29,017,053
|
)
|
|
(30,517,139
|
)
|
|
Proceeds from secured loans
|
—
|
|
|
125,000
|
|
|
Principal repayments of secured loans
|
—
|
|
|
(125,000
|
)
|
|
Principal repayments of exchangeable senior notes
|
(153,750
|
)
|
|
—
|
|
|
Payments of deferred costs
|
—
|
|
|
(140
|
)
|
|
Payments of dividends and distributions
|
(50,924
|
)
|
|
(51,734
|
)
|
|
Net cash provided by (used in) financing activities
|
928,004
|
|
|
(1,137,394
|
)
|
|
Net change in cash and cash equivalents
|
(105,911
|
)
|
|
(1,863
|
)
|
|
Cash and cash equivalents, beginning of period
|
161,788
|
|
|
53,199
|
|
|
Cash and cash equivalents, end of period
|
55,877
|
|
|
51,336
|
|
|
Supplement Disclosure of Cash Flow Information
|
|
|
|
||
|
Interest paid
|
51,058
|
|
|
43,110
|
|
|
Non-cash Investing and Financing Activities Information
|
|
|
|
||
|
Net change in unrealized gain (loss) on mortgage-backed and credit risk transfer securities
|
(17,139
|
)
|
|
110,916
|
|
|
Dividends and distributions declared not paid
|
50,928
|
|
|
50,917
|
|
|
Net change in investment related payable (receivable)
|
174,217
|
|
|
131,413
|
|
|
Net change in repurchase agreements, not settled
|
(1,416
|
)
|
|
—
|
|
|
Swap terminated, not settled
|
—
|
|
|
4,272
|
|
|
Change in due from counterparties
|
86,450
|
|
|
(7,109
|
)
|
|
|
5
|
|
|
•
|
Residential mortgage-backed securities ("RMBS") that are guaranteed by a U.S. government agency such as the Government National Mortgage Association, or a federally chartered corporation such as the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation (collectively "Agency RMBS");
|
|
•
|
RMBS that are not guaranteed by a U.S. government agency (“non-Agency RMBS”);
|
|
•
|
Credit risk transfer securities that are unsecured obligations issued by government-sponsored enterprises ("GSE CRT");
|
|
•
|
Commercial mortgage-backed securities ("CMBS");
|
|
•
|
Residential and commercial mortgage loans; and
|
|
•
|
Other real estate-related financing agreements.
|
|
|
6
|
|
|
$ in thousands
|
Carrying Amount
|
|
Company's Maximum Risk of Loss
|
||
|
CMBS
|
2,669,070
|
|
|
2,669,070
|
|
|
Non-Agency RMBS
|
1,774,088
|
|
|
1,774,088
|
|
|
Investments in unconsolidated ventures
|
33,336
|
|
|
33,336
|
|
|
Total
|
4,476,494
|
|
|
4,476,494
|
|
|
|
7
|
|
|
March 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
$ in thousands
|
Principal/ Notional
Balance
|
|
Unamortized
Premium
(Discount)
|
|
Amortized
Cost
|
|
Unrealized
Gain/
(Loss), net
|
|
Fair
Value
|
|
Net
Weighted
Average
Coupon
(1)
|
|
Period-
end
Weighted
Average
Yield
(2)
|
|
Quarterly
Weighted
Average
Yield
(3)
|
||||||||
|
Agency RMBS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
15 year fixed-rate
|
3,328,574
|
|
|
143,271
|
|
|
3,471,845
|
|
|
(53,614
|
)
|
|
3,418,231
|
|
|
3.10
|
%
|
|
2.19
|
%
|
|
2.03
|
%
|
|
30 year fixed-rate
|
4,262,025
|
|
|
218,000
|
|
|
4,480,025
|
|
|
12,299
|
|
|
4,492,324
|
|
|
4.04
|
%
|
|
2.95
|
%
|
|
2.64
|
%
|
|
ARM
*
|
283,979
|
|
|
2,258
|
|
|
286,237
|
|
|
4,453
|
|
|
290,690
|
|
|
2.69
|
%
|
|
2.61
|
%
|
|
2.31
|
%
|
|
Hybrid ARM
|
2,050,405
|
|
|
31,786
|
|
|
2,082,191
|
|
|
19,128
|
|
|
2,101,319
|
|
|
2.69
|
%
|
|
2.53
|
%
|
|
2.29
|
%
|
|
Total Agency pass-through
(4)
|
9,924,983
|
|
|
395,315
|
|
|
10,320,298
|
|
|
(17,734
|
)
|
|
10,302,564
|
|
|
3.41
|
%
|
|
2.60
|
%
|
|
2.36
|
%
|
|
Agency-CMO
(5)
|
1,548,330
|
|
|
(1,226,067
|
)
|
|
322,263
|
|
|
(2,545
|
)
|
|
319,718
|
|
|
2.10
|
%
|
|
2.01
|
%
|
|
0.58
|
%
|
|
Non-Agency RMBS
(6)(7)(8)
|
3,530,751
|
|
|
(1,854,807
|
)
|
|
1,675,944
|
|
|
98,144
|
|
|
1,774,088
|
|
|
2.20
|
%
|
|
5.72
|
%
|
|
5.58
|
%
|
|
GSE CRT
(9)(10)
|
772,404
|
|
|
25,885
|
|
|
798,289
|
|
|
57,368
|
|
|
855,657
|
|
|
2.82
|
%
|
|
2.31
|
%
|
|
2.15
|
%
|
|
CMBS
(11)(12)
|
3,201,930
|
|
|
(591,152
|
)
|
|
2,610,778
|
|
|
58,292
|
|
|
2,669,070
|
|
|
3.80
|
%
|
|
4.39
|
%
|
|
4.20
|
%
|
|
Total
|
18,978,398
|
|
|
(3,250,826
|
)
|
|
15,727,572
|
|
|
193,525
|
|
|
15,921,097
|
|
|
3.12
|
%
|
|
3.20
|
%
|
|
2.97
|
%
|
|
(1)
|
Net weighted average coupon as of
March 31, 2017
is presented net of servicing and other fees.
|
|
(2)
|
Period-end weighted average yield is based on amortized cost as of
March 31, 2017
and incorporates future prepayment and loss assumptions.
|
|
(3)
|
Quarterly weighted average portfolio yield for the period was calculated by dividing interest income, including amortization of premiums and discounts, by the average balance of the amortized cost of the investments. All yields are annualized.
|
|
(4)
|
We have elected the fair value option for Agency RMBS purchased on or after September 1, 2016 which represent
17.6%
of principal/notional balance,
17.4%
of amortized cost and
17.4%
of fair value.
|
|
(5)
|
Agency collateralized mortgage obligation ("Agency-CMO") includes interest-only securities ("Agency IO"), which represent
84.7%
of principal/notional balance,
25.8%
of amortized cost and
25.8%
of fair value.
|
|
(6)
|
Non-Agency RMBS held by us is
47.3%
fixed rate,
45.4%
variable rate, and
7.3%
floating rate based on fair value.
|
|
(7)
|
Of the total discount in non-Agency RMBS,
$252.7 million
is non-accretable based on estimated future cash flows of the securities.
|
|
(8)
|
Non-Agency RMBS includes interest-only securities which represent
45.4%
of principal/notional balance,
1.6%
of amortized cost and
1.4%
of fair value.
|
|
(9)
|
We have elected the fair value option for GSE CRT purchased on or after August 24, 2015, which represent
25.8%
of the balance based on fair value. As a result, GSE CRT accounted for under the fair value option are not bifurcated between the debt host contract and the embedded derivative.
|
|
(10)
|
GSE CRT weighted average coupon and weighted average yield excludes coupon interest associated with embedded derivatives not accounted for under the fair value option recorded as realized and unrealized credit derivative income (loss), net.
|
|
(11)
|
CMBS includes interest-only securities which represent
19.3%
of principal/notional balance,
0.7%
of amortized cost and
0.8%
of fair value.
|
|
(12)
|
We have elected the fair value option for CMBS purchased on or after September 1, 2016 which represent
9.0%
of principal/notional balance,
7.9%
of amortized cost and
7.7%
of fair value.
|
|
|
8
|
|
|
December 31, 2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
$ in thousands
|
Principal/Notional
Balance
|
|
Unamortized
Premium
(Discount)
|
|
Amortized
Cost
|
|
Unrealized
Gain/
(Loss), net
|
|
Fair
Value
|
|
Net
Weighted
Average
Coupon
(1)
|
|
Period-
end
Weighted
Average
Yield
(2)
|
|
Quarterly
Weighted
Average
Yield
(3)
|
||||||||
|
Agency RMBS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
15 year fixed-rate
|
3,460,625
|
|
|
151,526
|
|
|
3,612,151
|
|
|
(54,223
|
)
|
|
3,557,928
|
|
|
3.11
|
%
|
|
2.19
|
%
|
|
1.99
|
%
|
|
30 year fixed-rate
|
2,780,806
|
|
|
185,521
|
|
|
2,966,327
|
|
|
15,390
|
|
|
2,981,717
|
|
|
4.37
|
%
|
|
2.61
|
%
|
|
2.57
|
%
|
|
ARM
|
301,900
|
|
|
2,520
|
|
|
304,420
|
|
|
3,453
|
|
|
307,873
|
|
|
2.69
|
%
|
|
2.59
|
%
|
|
2.16
|
%
|
|
Hybrid ARM
|
2,423,152
|
|
|
42,360
|
|
|
2,465,512
|
|
|
8,789
|
|
|
2,474,301
|
|
|
2.70
|
%
|
|
2.52
|
%
|
|
2.02
|
%
|
|
Total Agency pass-through
(4)
|
8,966,483
|
|
|
381,927
|
|
|
9,348,410
|
|
|
(26,591
|
)
|
|
9,321,819
|
|
|
3.37
|
%
|
|
2.42
|
%
|
|
2.20
|
%
|
|
Agency-CMO
(5)
|
1,712,120
|
|
|
(1,368,916
|
)
|
|
343,204
|
|
|
837
|
|
|
344,041
|
|
|
2.16
|
%
|
|
3.08
|
%
|
|
2.07
|
%
|
|
Non-Agency RMBS
(6)(7)(8)
|
3,838,314
|
|
|
(1,934,269
|
)
|
|
1,904,045
|
|
|
91,506
|
|
|
1,995,551
|
|
|
2.21
|
%
|
|
5.22
|
%
|
|
5.22
|
%
|
|
GSE CRT
(9)(10)
|
707,899
|
|
|
24,320
|
|
|
732,219
|
|
|
35,981
|
|
|
768,200
|
|
|
2.38
|
%
|
|
1.51
|
%
|
|
1.24
|
%
|
|
CMBS
(11)(12)
|
3,050,747
|
|
|
(559,857
|
)
|
|
2,490,890
|
|
|
60,830
|
|
|
2,551,720
|
|
|
3.80
|
%
|
|
4.21
|
%
|
|
4.17
|
%
|
|
Total
|
18,275,563
|
|
|
(3,456,795
|
)
|
|
14,818,768
|
|
|
162,563
|
|
|
14,981,331
|
|
|
3.05
|
%
|
|
3.05
|
%
|
|
2.87
|
%
|
|
(1)
|
Net weighted average coupon as of
December 31, 2016
is presented net of servicing and other fees.
|
|
(2)
|
Period-end weighted average yield is based on amortized cost as of
December 31, 2016
and incorporates future prepayment and loss assumptions.
|
|
(3)
|
Quarterly weighted average portfolio yield for the period was calculated by dividing interest income, including amortization of premiums and discounts, by the average of the amortized cost of the investments. All yields are annualized.
|
|
(4)
|
We have elected the fair value option for Agency RMBS purchased on or after September 1, 2016 which represent
4.3%
of principal/notional balance,
4.3%
of amortized cost and
4.2%
of fair value.
|
|
(5)
|
Agency collateralized mortgage obligation ("Agency CMO") includes interest-only securities ("Agency IO"), which represent
85.5%
o
f principal (notional) balance,
26.8%
of amortized cost and
21.7%
of fair value.
|
|
(6)
|
Non-Agency RMBS held by us is
45.5%
variable rate,
47.2%
fixed rate, and
7.3%
floating rate based on fair value.
|
|
(7)
|
Of the total discount in non-Agency RMBS,
$252.5 million
is non-accretable based on estimated future cash flows of the securities.
|
|
(8)
|
Non-Agency RMBS includes interest-only securities, which represent
43.5%
of principal/notional balance,
1.5%
of amortized cost and
1.3%
of fair value.
|
|
(9)
|
We have elected the fair value option for GSE CRT purchased on or after August 24, 2015, which represent
19.2%
of the balance based on fair value. As a result, GSE CRT accounted for under the fair value option are not bifurcated between the debt host contract and the embedded derivative.
|
|
(10)
|
GSE CRT weighted average coupon and weighted average yield excludes coupon interest associated with embedded derivatives not accounted for under the fair value option recorded as realized and unrealized credit derivative income (loss), net.
|
|
(11)
|
CMBS includes interest-only securities which represent
20.3%
of principal/notional balance,
0.8%
of amortized cost and
0.9%
of fair value.
|
|
(12)
|
We have elected the fair value option for CMBS purchased on or after September 1, 2016 which represent
0.4%
of principal/notional balance,
0.6%
of amortized cost and
0.5%
of fair value.
|
|
$ in thousands
|
March 31, 2017
|
|
% of Non-Agency
|
|
December 31, 2016
|
|
% of Non-Agency
|
||||
|
Prime
|
855,877
|
|
|
48.2
|
%
|
|
889,658
|
|
|
44.6
|
%
|
|
Alt-A
|
431,426
|
|
|
24.3
|
%
|
|
447,213
|
|
|
22.4
|
%
|
|
Re-REMIC
|
265,607
|
|
|
15.0
|
%
|
|
364,301
|
|
|
18.2
|
%
|
|
Subprime/reperforming
|
221,178
|
|
|
12.5
|
%
|
|
294,379
|
|
|
14.8
|
%
|
|
Total Non-Agency
|
1,774,088
|
|
|
100.0
|
%
|
|
1,995,551
|
|
|
100.0
|
%
|
|
|
9
|
|
|
|
Percentage of Re-REMIC Holdings at Fair Value
|
||||
|
Re-REMIC Subordination
(1)
|
March 31, 2017
|
|
December 31, 2016
|
||
|
0% - 10%
|
23.8
|
%
|
|
17.6
|
%
|
|
10% - 20%
|
4.0
|
%
|
|
7.4
|
%
|
|
20% - 30%
|
9.9
|
%
|
|
13.5
|
%
|
|
30% - 40%
|
19.1
|
%
|
|
15.7
|
%
|
|
40% - 50%
|
21.7
|
%
|
|
27.0
|
%
|
|
50% - 60%
|
19.7
|
%
|
|
16.1
|
%
|
|
60% - 70%
|
1.8
|
%
|
|
2.7
|
%
|
|
Total
|
100.0
|
%
|
|
100.0
|
%
|
|
(1)
|
Subordination refers to the credit enhancement provided to the Re-REMIC tranche held by us by any junior Re-REMIC tranche or tranches in a resecuritization. This figure reflects the percentage of the balance of the underlying securities represented by any junior tranche or tranches at the time of resecuritization. Generally, principal losses on the underlying securities in excess of the subordination amount would result in principal losses on the Re-REMIC tranche held by us.
45.0%
of our Re-REMIC holdings are not senior tranches.
|
|
$ in thousands
|
March 31, 2017
|
|
December 31, 2016
|
||
|
Principal balance
|
18,978,398
|
|
|
18,275,563
|
|
|
Unamortized premium
|
485,364
|
|
|
476,314
|
|
|
Unamortized discount
|
(3,736,190
|
)
|
|
(3,933,109
|
)
|
|
Gross unrealized gains
|
329,271
|
|
|
302,099
|
|
|
Gross unrealized losses
|
(135,746
|
)
|
|
(139,536
|
)
|
|
Fair value
|
15,921,097
|
|
|
14,981,331
|
|
|
$ in thousands
|
March 31, 2017
|
|
December 31, 2016
|
||
|
Less than one year
|
109,860
|
|
|
121,076
|
|
|
Greater than one year and less than five years
|
6,842,335
|
|
|
6,719,923
|
|
|
Greater than or equal to five years
|
8,968,902
|
|
|
8,140,332
|
|
|
Total
|
15,921,097
|
|
|
14,981,331
|
|
|
|
10
|
|
|
|
Less than 12 Months
|
|
12 Months or More
|
|
Total
|
|||||||||||||||||||||
|
$ in thousands
|
Fair
Value
|
|
Unrealized
Losses
|
|
Number
of
Securities
|
|
Fair
Value
|
|
Unrealized
Losses
|
|
Number
of
Securities
|
|
Fair
Value
|
|
Unrealized
Losses
|
|
Number
of
Securities
|
|||||||||
|
Agency RMBS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
15 year fixed-rate
|
2,674,548
|
|
|
(65,750
|
)
|
|
123
|
|
|
62,208
|
|
|
(1,287
|
)
|
|
18
|
|
|
2,736,756
|
|
|
(67,037
|
)
|
|
141
|
|
|
30 year fixed-rate
|
1,531,154
|
|
|
(18,908
|
)
|
|
62
|
|
|
527,591
|
|
|
(18,801
|
)
|
|
27
|
|
|
2,058,745
|
|
|
(37,709
|
)
|
|
89
|
|
|
ARM
|
22,748
|
|
|
(4
|
)
|
|
2
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
22,748
|
|
|
(4
|
)
|
|
2
|
|
|
Hybrid ARM
|
675,408
|
|
|
(3,219
|
)
|
|
49
|
|
|
5,415
|
|
|
(36
|
)
|
|
3
|
|
|
680,823
|
|
|
(3,255
|
)
|
|
52
|
|
|
Total Agency pass-through
(1)
|
4,903,858
|
|
|
(87,881
|
)
|
|
236
|
|
|
595,214
|
|
|
(20,124
|
)
|
|
48
|
|
|
5,499,072
|
|
|
(108,005
|
)
|
|
284
|
|
|
Agency-CMO
(2)
|
139,050
|
|
|
(6,246
|
)
|
|
26
|
|
|
25,773
|
|
|
(1,492
|
)
|
|
5
|
|
|
164,823
|
|
|
(7,738
|
)
|
|
31
|
|
|
Non-Agency RMBS
|
210,776
|
|
|
(4,911
|
)
|
|
34
|
|
|
279,410
|
|
|
(5,060
|
)
|
|
34
|
|
|
490,186
|
|
|
(9,971
|
)
|
|
68
|
|
|
GSE CRT
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
CMBS
(3)
|
570,812
|
|
|
(9,447
|
)
|
|
54
|
|
|
19,950
|
|
|
(585
|
)
|
|
5
|
|
|
590,762
|
|
|
(10,032
|
)
|
|
59
|
|
|
Total
|
5,824,496
|
|
|
(108,485
|
)
|
|
350
|
|
|
920,347
|
|
|
(27,261
|
)
|
|
92
|
|
|
6,744,843
|
|
|
(135,746
|
)
|
|
442
|
|
|
(1)
|
Amounts disclosed include Agency RMBS with a fair value of $
901.1 million
for which the fair value option has been elected. Such securities have unrealized losses of $
6.4 million
.
|
|
(2)
|
Fair value includes unrealized losses on Agency IO of
$4.6 million
and unrealized losses on CMO of
$3.2 million
.
|
|
(3)
|
Amounts disclosed includes CMBS with a fair value of
$176.1 million
for which the fair value option has been elected. Such securities have unrealized losses of
$3.3 million
.
|
|
|
Less than 12 Months
|
|
12 Months or More
|
|
Total
|
|||||||||||||||||||||
|
$ in thousands
|
Fair
Value
|
|
Unrealized
Losses
|
|
Number
of
Securities
|
|
Fair
Value
|
|
Unrealized
Losses
|
|
Number
of
Securities
|
|
Fair
Value
|
|
Unrealized
Losses
|
|
Number
of
Securities
|
|||||||||
|
Agency RMBS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
15 year fixed-rate
|
2,781,777
|
|
|
(66,506
|
)
|
|
127
|
|
|
65,964
|
|
|
(1,556
|
)
|
|
17
|
|
|
2,847,741
|
|
|
(68,062
|
)
|
|
144
|
|
|
30 year fixed-rate
|
747,719
|
|
|
(15,409
|
)
|
|
45
|
|
|
547,763
|
|
|
(18,004
|
)
|
|
27
|
|
|
1,295,482
|
|
|
(33,413
|
)
|
|
72
|
|
|
ARM
|
120,540
|
|
|
(326
|
)
|
|
9
|
|
|
1,091
|
|
|
(7
|
)
|
|
1
|
|
|
121,631
|
|
|
(333
|
)
|
|
10
|
|
|
Hybrid ARM
|
1,356,687
|
|
|
(9,922
|
)
|
|
99
|
|
|
252
|
|
|
(4
|
)
|
|
2
|
|
|
1,356,939
|
|
|
(9,926
|
)
|
|
101
|
|
|
Total Agency pass-through
(1)
|
5,006,723
|
|
|
(92,163
|
)
|
|
280
|
|
|
615,070
|
|
|
(19,571
|
)
|
|
47
|
|
|
5,621,793
|
|
|
(111,734
|
)
|
|
327
|
|
|
Agency-CMO
(2)
|
163,114
|
|
|
(3,812
|
)
|
|
28
|
|
|
22,792
|
|
|
(952
|
)
|
|
3
|
|
|
185,906
|
|
|
(4,764
|
)
|
|
31
|
|
|
Non-Agency RMBS
|
287,647
|
|
|
(7,861
|
)
|
|
42
|
|
|
497,863
|
|
|
(6,671
|
)
|
|
36
|
|
|
785,510
|
|
|
(14,532
|
)
|
|
78
|
|
|
GSE CRT
(3)
|
—
|
|
|
—
|
|
|
—
|
|
|
35,935
|
|
|
(969
|
)
|
|
3
|
|
|
35,935
|
|
|
(969
|
)
|
|
3
|
|
|
CMBS
(4)
|
401,016
|
|
|
(6,733
|
)
|
|
36
|
|
|
47,219
|
|
|
(804
|
)
|
|
6
|
|
|
448,235
|
|
|
(7,537
|
)
|
|
42
|
|
|
Total
|
5,858,500
|
|
|
(110,569
|
)
|
|
386
|
|
|
1,218,879
|
|
|
(28,967
|
)
|
|
95
|
|
|
7,077,379
|
|
|
(139,536
|
)
|
|
481
|
|
|
(1)
|
Amounts disclosed include Agency RMBS with a fair value of
$149.7 million
for which the fair value option has been elected. Such securities have unrealized losses of
$4.0 million
.
|
|
(2)
|
Fair value includes unrealized losses on Agency IO of
$3.0 million
unrealized losses and unrealized losses on CMO of
$1.7 million
.
|
|
(3)
|
Fair value includes unrealized losses on both the debt host contract and the embedded derivative.
|
|
(4)
|
Amounts disclosed includes CMBS with a fair value of
$13.9 million
for which the fair value option has been elected. Such securities have unrealized losses of
$613,000
.
|
|
|
11
|
|
|
$ in thousands
|
Three Months
ended March 31, 2017 |
|
Three Months
ended March 31, 2016 |
||
|
Cumulative credit loss at beginning of period
|
8,909
|
|
|
—
|
|
|
Additions:
|
|
|
|
||
|
Other-than-temporary impairments not previously recognized
|
349
|
|
|
5,683
|
|
|
Increases related to other-than-temporary impairments on securities with previously recognized other-than-temporary impairments
|
183
|
|
|
—
|
|
|
Cumulative credit loss at end of period
|
9,441
|
|
|
5,683
|
|
|
$ in thousands
|
Three Months
ended March 31, 2017 |
|
Three Months
ended March 31, 2016 |
||
|
Accumulated other comprehensive income (loss) from MBS and GSE CRT securities:
|
|
|
|
||
|
Unrealized gain (loss) on MBS and GSE CRT at beginning of period
|
146,301
|
|
|
177,799
|
|
|
Unrealized gain (loss) on MBS and GSE CRT
|
16,289
|
|
|
121,460
|
|
|
Reclassification of unrealized (gain) loss on sale of MBS and GSE CRT to gain (loss) on investments, net
|
850
|
|
|
(10,544
|
)
|
|
Balance at the end of period
|
163,440
|
|
|
288,715
|
|
|
|
12
|
|
|
$ in thousands
|
Three Months
ended March 31, 2017 |
|
Three Months
ended March 31, 2016 |
||
|
Gross realized gain on sale of investments
|
904
|
|
|
13,015
|
|
|
Gross realized loss on sale of investments
|
(1,911
|
)
|
|
(2,471
|
)
|
|
Other-than-temporary impairment losses
|
(532
|
)
|
|
(5,683
|
)
|
|
Net unrealized gains and losses on MBS accounted for under the fair value option
|
(3,602
|
)
|
|
6,676
|
|
|
Net unrealized gains and losses on GSE CRT accounted for under the fair value option
|
3,279
|
|
|
64
|
|
|
Net unrealized gains and losses on trading securities
|
9
|
|
|
—
|
|
|
Total gain (loss) on investments, net
|
(1,853
|
)
|
|
11,601
|
|
|
$ in thousands
|
Coupon
Interest
|
|
Net (Premium
Amortization)/Discount
Accretion
|
|
Interest
Income
|
|||
|
Agency
|
91,231
|
|
|
(28,578
|
)
|
|
62,653
|
|
|
Non-Agency
|
20,614
|
|
|
4,387
|
|
|
25,001
|
|
|
GSE CRT
|
4,487
|
|
|
(371
|
)
|
|
4,116
|
|
|
CMBS
|
29,676
|
|
|
(2,634
|
)
|
|
27,042
|
|
|
Other
|
61
|
|
|
—
|
|
|
61
|
|
|
Total
|
146,069
|
|
|
(27,196
|
)
|
|
118,873
|
|
|
$ in thousands
|
Coupon
Interest
|
|
Net (Premium
Amortization)/Discount
Accretion
|
|
Interest
Income
|
|||
|
Agency
|
85,771
|
|
|
(24,185
|
)
|
|
61,586
|
|
|
Non-Agency
|
25,849
|
|
|
3,844
|
|
|
29,693
|
|
|
GSE CRT
|
2,197
|
|
|
(767
|
)
|
|
1,430
|
|
|
CMBS
|
32,264
|
|
|
(2,940
|
)
|
|
29,324
|
|
|
Other
|
213
|
|
|
—
|
|
|
213
|
|
|
Total
|
146,294
|
|
|
(24,048
|
)
|
|
122,246
|
|
|
|
13
|
|
|
$ in thousands
|
Number of
loans
|
|
Principal
Balance
|
|
Unamortized (fees)/
costs, net
|
|
Carrying
value
|
|
Weighted Average Coupon
|
|
Weighted Average Years to Maturity
(1)
|
|||||
|
Mezzanine loans
|
10
|
|
|
276,175
|
|
|
(231
|
)
|
|
275,944
|
|
|
8.29
|
%
|
|
1.5
|
|
Total
|
10
|
|
|
276,175
|
|
|
(231
|
)
|
|
275,944
|
|
|
8.29
|
%
|
|
1.5
|
|
$ in thousands
|
Number of
loans
|
|
Principal
Balance
|
|
Unamortized (fees)/
costs, net
|
|
Carrying
value
|
|
Weighted Average Coupon
|
|
Weighted Average Years to Maturity
(1)
|
|||||
|
Mezzanine loans
|
10
|
|
|
273,666
|
|
|
(311
|
)
|
|
273,355
|
|
|
8.14
|
%
|
|
1.6
|
|
Total
|
10
|
|
|
273,666
|
|
|
(311
|
)
|
|
273,355
|
|
|
8.14
|
%
|
|
1.6
|
|
(1)
|
Weighted average years to maturity is based on the contractual maturity date. Certain loans may contain either an option to prepay or an option to extend beyond their contractual maturity dates as specified in the respective loan agreements.
|
|
$ in thousands
|
March 31, 2017
|
|
December 31, 2016
|
||
|
FHLBI stock
|
74,250
|
|
|
74,250
|
|
|
Investments in unconsolidated ventures
|
33,336
|
|
|
33,301
|
|
|
Investment in exchange-traded fund
|
4,017
|
|
|
500
|
|
|
Prepaid expenses and other assets
|
1,354
|
|
|
1,246
|
|
|
Total
|
112,957
|
|
|
109,297
|
|
|
|
14
|
|
|
$ in thousands
|
March 31, 2017
|
|||||||
|
|
|
|
|
Weighted
|
||||
|
|
|
Weighted
|
|
Average
|
||||
|
|
|
Average
|
|
Remaining
|
||||
|
Amount
|
|
Interest
|
|
Maturity
|
||||
|
Outstanding
|
|
Rate
|
|
(days)
|
||||
|
Repurchase Agreements:
|
|
|
|
|
|
|||
|
Agency RMBS
|
9,335,954
|
|
|
1.00
|
%
|
|
19
|
|
|
Non-Agency RMBS
|
1,297,265
|
|
|
2.27
|
%
|
|
29
|
|
|
GSE CRT
|
624,270
|
|
|
2.41
|
%
|
|
18
|
|
|
CMBS
|
1,032,410
|
|
|
2.11
|
%
|
|
21
|
|
|
Total Repurchase Agreements
|
12,289,899
|
|
|
1.30
|
%
|
|
20
|
|
|
Secured Loans
|
1,650,000
|
|
|
0.94
|
%
|
|
2,592
|
|
|
Exchangeable Senior Notes
(1)
|
250,000
|
|
|
5.00
|
%
|
|
349
|
|
|
Total Borrowings
|
14,189,899
|
|
|
1.32
|
%
|
|
325
|
|
|
$ in thousands
|
December 31, 2016
|
|||||||
|
|
|
|
|
Weighted
|
||||
|
|
|
Weighted
|
|
Average
|
||||
|
|
|
Average
|
|
Remaining
|
||||
|
Amount
|
|
Interest
|
|
Maturity
|
||||
|
Outstanding
|
|
Rate
|
|
(days)
|
||||
|
Repurchase Agreements:
|
|
|
|
|
|
|||
|
Agency RMBS
|
8,148,220
|
|
|
0.93
|
%
|
|
32
|
|
|
Non-Agency RMBS
|
1,519,859
|
|
|
2.06
|
%
|
|
28
|
|
|
GSE CRT
|
547,872
|
|
|
2.25
|
%
|
|
16
|
|
|
CMBS
|
944,718
|
|
|
1.86
|
%
|
|
16
|
|
|
Total Repurchase Agreements
|
11,160,669
|
|
|
1.23
|
%
|
|
30
|
|
|
Secured Loans
|
1,650,000
|
|
|
0.74
|
%
|
|
2,682
|
|
|
Exchangeable Senior Notes
(1)
|
400,000
|
|
|
5.00
|
%
|
|
439
|
|
|
Total Borrowings
|
13,210,669
|
|
|
1.28
|
%
|
|
373
|
|
|
(1)
|
The carrying value of exchangeable senior notes is
$248.5 million
and
$397.0 million
as of
March 31, 2017
and
December 31, 2016
, respectively. The carrying value is net of debt issuance costs of
$1.5 million
and
$3.0 million
as of
March 31, 2017
and
December 31, 2016
, respectively.
|
|
$ in thousands
|
As of March 31,
|
|
|
2018
|
12,539,899
|
|
|
2019
|
—
|
|
|
2020
|
300,000
|
|
|
2021
|
100,000
|
|
|
2022
|
—
|
|
|
Thereafter
|
1,250,000
|
|
|
Total
|
14,189,899
|
|
|
|
15
|
|
|
March 31, 2017
|
|
|
|
|
|
|||
|
$ in thousands
|
Amount Outstanding
|
|
Percent of Total Amount Outstanding
|
|
MBS and GSE CRT Pledged as Collateral
(1)
|
|||
|
Repurchase Agreement Counterparties:
|
|
|
|
|
|
|||
|
HSBC Securities (USA) Inc
|
1,435,609
|
|
|
10.3
|
%
|
|
1,504,531
|
|
|
ING Financial Market LLC
|
1,367,581
|
|
|
9.8
|
%
|
|
1,449,055
|
|
|
Pierpont Securities LLC
|
1,174,293
|
|
|
8.4
|
%
|
|
1,235,839
|
|
|
Royal Bank of Canada
|
1,101,290
|
|
|
7.9
|
%
|
|
1,297,732
|
|
|
Mitsubishi UFJ Securities (USA), Inc.
|
706,479
|
|
|
5.1
|
%
|
|
747,029
|
|
|
Industrial and Commercial Bank of China Financial Services LLC
|
649,721
|
|
|
4.7
|
%
|
|
685,868
|
|
|
Scotia Capital
|
615,633
|
|
|
4.4
|
%
|
|
645,427
|
|
|
E D & F Man Capital Markets Inc
|
535,907
|
|
|
3.8
|
%
|
|
567,809
|
|
|
South Street Securities LLC
|
511,931
|
|
|
3.7
|
%
|
|
538,155
|
|
|
JP Morgan Securities Inc.
|
450,553
|
|
|
3.2
|
%
|
|
522,448
|
|
|
KGS-Alpha Capital Markets, L.P.
|
422,352
|
|
|
3.0
|
%
|
|
447,141
|
|
|
Societe Generale
|
399,239
|
|
|
2.9
|
%
|
|
514,425
|
|
|
Goldman, Sachs & Co.
|
394,291
|
|
|
2.8
|
%
|
|
510,037
|
|
|
Citigroup Global Markets Inc.
|
383,440
|
|
|
2.8
|
%
|
|
491,145
|
|
|
Natixis, New York Branch
|
346,827
|
|
|
2.5
|
%
|
|
374,779
|
|
|
Guggenheim Liquidity Services, LLC
|
339,976
|
|
|
2.4
|
%
|
|
358,674
|
|
|
BNP Paribas Securities Corp.
|
294,341
|
|
|
2.1
|
%
|
|
330,253
|
|
|
Daiwa Capital Markets America Inc
|
233,117
|
|
|
1.7
|
%
|
|
249,468
|
|
|
All other counterparties
(2)
|
927,319
|
|
|
6.7
|
%
|
|
1,133,144
|
|
|
Total Repurchase Agreement Counterparties
|
12,289,899
|
|
|
88.2
|
%
|
|
13,602,959
|
|
|
Secured Loans Counterparty:
|
|
|
|
|
|
|||
|
FHLBI
|
1,650,000
|
|
|
11.8
|
%
|
|
1,917,029
|
|
|
Total
|
13,939,899
|
|
|
100.0
|
%
|
|
15,519,988
|
|
|
(1)
|
Amount pledged as collateral is measured at fair value as described in Note 2 - "Summary of Significant Accounting Policies" included in the consolidated financial statements of our Annual Report on Form 10-K for the year ended
December 31, 2016
.
|
|
(2)
|
Represents amounts outstanding with
seven
counterparties.
|
|
|
16
|
|
|
December 31, 2016
|
|
|
|
|
|
|||
|
$ in thousands
|
Amount Outstanding
|
|
Percent of Total Amount Outstanding
|
|
MBS and GSE CRT Pledged as Collateral
(1)
|
|||
|
Repurchase Agreement Counterparties:
|
|
|
|
|
|
|||
|
HSBC Securities (USA) Inc
|
1,401,966
|
|
|
11.2
|
%
|
|
1,468,793
|
|
|
ING Financial Market LLC
|
1,142,200
|
|
|
8.9
|
%
|
|
1,216,492
|
|
|
Royal Bank of Canada
|
1,098,631
|
|
|
8.6
|
%
|
|
1,293,336
|
|
|
Industrial and Commercial Bank of China Financial Services LLC
|
707,616
|
|
|
5.5
|
%
|
|
748,503
|
|
|
Mitsubishi UFJ Securities (USA), Inc.
|
703,382
|
|
|
5.5
|
%
|
|
740,404
|
|
|
Pierpont Securities LLC
|
681,853
|
|
|
5.3
|
%
|
|
717,663
|
|
|
South Street Securities LLC
|
675,660
|
|
|
5.3
|
%
|
|
713,330
|
|
|
Goldman, Sachs & Co.
|
486,430
|
|
|
3.8
|
%
|
|
623,400
|
|
|
Scotia Capital
|
479,105
|
|
|
3.7
|
%
|
|
500,578
|
|
|
JP Morgan Securities Inc.
|
477,947
|
|
|
3.7
|
%
|
|
554,494
|
|
|
KGS-Alpha Capital Markets, L.P.
|
441,541
|
|
|
3.4
|
%
|
|
475,858
|
|
|
Citigroup Global Markets Inc.
|
427,185
|
|
|
3.3
|
%
|
|
534,875
|
|
|
E D & F Man Capital Markets Inc.
|
405,615
|
|
|
3.2
|
%
|
|
430,896
|
|
|
Guggenheim Liquidity Services, LLC
|
356,149
|
|
|
2.8
|
%
|
|
377,030
|
|
|
Natixis, New York Branch
|
336,202
|
|
|
2.6
|
%
|
|
362,432
|
|
|
Societe Generale
|
325,393
|
|
|
2.5
|
%
|
|
427,200
|
|
|
BNP Paribas Securities Corp.
|
307,641
|
|
|
2.4
|
%
|
|
346,484
|
|
|
All other counterparties
(2)
|
706,153
|
|
|
5.4
|
%
|
|
912,536
|
|
|
Total Repurchase Agreement Counterparties:
|
11,160,669
|
|
|
87.1
|
%
|
|
12,444,304
|
|
|
Secured Loans Counterparty:
|
|
|
|
|
|
|||
|
FHLBI
|
1,650,000
|
|
|
12.9
|
%
|
|
1,931,582
|
|
|
Total
|
12,810,669
|
|
|
100.0
|
%
|
|
14,375,886
|
|
|
(1)
|
Amount pledged as collateral is measured at fair value as described in Note 2 - "Summary of Significant Accounting Policies" included in the consolidated financial statements of our Annual Report on Form 10-K for the year ended
December 31, 2016
.
|
|
(2)
|
Represents amounts outstanding with
seven
counterparties.
|
|
|
17
|
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||
|
Repurchase Agreements:
|
|
|
|
||
|
Agency RMBS
|
9,870,197
|
|
|
8,654,233
|
|
|
Non-Agency RMBS
|
1,617,836
|
|
|
1,887,550
|
|
|
GSE CRT
|
829,431
|
|
|
734,212
|
|
|
CMBS
|
1,285,495
|
|
|
1,168,309
|
|
|
Total repurchase agreements collateral pledged
|
13,602,959
|
|
|
12,444,304
|
|
|
Secured Loans:
|
|
|
|
||
|
Agency RMBS
|
578,249
|
|
|
585,504
|
|
|
CMBS
|
1,338,780
|
|
|
1,346,078
|
|
|
Total secured loans collateral pledged
|
1,917,029
|
|
|
1,931,582
|
|
|
Interest Rate Swaps:
|
|
|
|
||
|
Agency RMBS
|
42,367
|
|
|
46,312
|
|
|
Cash
|
—
|
|
|
86,450
|
|
|
Total interest rate swaps collateral pledged
|
42,367
|
|
|
132,762
|
|
|
Total collateral pledged:
|
|
|
|
||
|
Mortgage-backed and GSE CRT securities
|
15,562,355
|
|
|
14,422,198
|
|
|
Cash
|
—
|
|
|
86,450
|
|
|
|
15,562,355
|
|
|
14,508,648
|
|
|
|
18
|
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||
|
Interest Rate Swaps:
|
|
|
|
||
|
Cash
|
3,732
|
|
|
1,700
|
|
|
Non-cash collateral
|
837
|
|
|
536
|
|
|
Total collateral held
|
4,569
|
|
|
2,236
|
|
|
$ in thousands
|
Notional Amount as
of January 1, 2017 |
|
Additions
|
|
Settlement,
Termination, Expiration or Exercise |
|
Notional Amount as
of March 31, 2017 |
||||
|
Interest Rate Swaps
|
6,500,000
|
|
|
1,150,000
|
|
|
—
|
|
|
7,650,000
|
|
|
Currency Forward Contracts
|
62,308
|
|
|
69,269
|
|
|
(65,576
|
)
|
|
66,001
|
|
|
Credit Derivatives
|
569,966
|
|
|
—
|
|
|
(3,007
|
)
|
|
566,959
|
|
|
Total
|
7,132,274
|
|
|
1,219,269
|
|
|
(68,583
|
)
|
|
8,282,960
|
|
|
|
19
|
|
|
$ in thousands
Counterparty |
|
Notional
|
|
Maturity Date
|
|
Fixed Interest Rate
in Contract |
|||
|
ING Capital Markets LLC
|
|
350,000
|
|
|
2/24/2018
|
|
0.95
|
%
|
|
|
UBS AG
|
|
500,000
|
|
|
5/24/2018
|
|
1.10
|
%
|
|
|
ING Capital Markets LLC
|
|
400,000
|
|
|
6/5/2018
|
|
0.87
|
%
|
|
|
CME Central Clea
ring
|
|
300,000
|
|
|
2/5/2021
|
|
2.50
|
%
|
|
|
CME Central Clea
ring
|
|
300,000
|
|
|
2/5/2021
|
|
2.69
|
%
|
|
|
Wells Fargo Bank, N.A.
|
|
200,000
|
|
|
3/15/2021
|
|
3.14
|
%
|
|
|
CME Central Clearing
|
|
500,000
|
|
|
5/24/2021
|
|
2.25
|
%
|
|
|
Citibank, N.A.
|
|
200,000
|
|
|
5/25/2021
|
|
2.83
|
%
|
|
|
CME Central Cl
earing
|
|
500,000
|
|
|
6/24/2021
|
|
2.44
|
%
|
|
|
HSBC Bank USA, Natio
nal Association
|
|
550,000
|
|
|
2/24/2022
|
|
2.45
|
%
|
|
|
CME Central Clearing
|
|
1,000,000
|
|
|
6/9/2022
|
|
2.21
|
%
|
|
|
The Royal Bank of Sc
otland Plc
|
|
500,000
|
|
|
8/15/2023
|
|
1.98
|
%
|
|
|
CME Central Clea
ring
|
|
600,000
|
|
|
8/24/2023
|
|
2.88
|
%
|
|
|
HSBC Bank USA, Nat
ional Association
|
|
500,000
|
|
|
12/15/2023
|
|
2.20
|
%
|
|
|
CME Central Clea
ring
|
|
450,000
|
|
|
1/12/2024
|
|
2.10
|
%
|
|
|
CME Central Clea
ring
|
|
450,000
|
|
|
1/25/2024
|
|
2.15
|
%
|
|
|
CME Central Clea
ring
|
|
100,000
|
|
|
4/2/2025
|
|
2.04
|
%
|
|
|
CME Central Clearing
|
(1
|
)
|
250,000
|
|
|
5/24/2028
|
|
2.78
|
%
|
|
Total
|
|
7,650,000
|
|
|
|
|
2.16
|
%
|
|
|
(1)
|
Forward start date of
5/24/2018
|
|
|
20
|
|
|
$ in thousand
|
March 31, 2017
|
|
December 31, 2016
|
||
|
Fair value amount
|
31,243
|
|
|
17,095
|
|
|
Notional amount
|
566,959
|
|
|
569,966
|
|
|
Maximum potential amount of future undiscounted payments
|
566,959
|
|
|
569,966
|
|
|
|
21
|
|
|
Derivative Assets
|
|
Derivative Liabilities
|
||||||||||||
|
|
|
As of March 31, 2017
|
|
As of December 31, 2016
|
|
|
|
As of March 31, 2017
|
|
As of December 31, 2016
|
||||
|
Balance
Sheet
|
|
Fair Value
|
|
Fair Value
|
|
Balance
Sheet
|
|
Fair Value
|
|
Fair Value
|
||||
|
Interest Rate Swaps Asset
|
|
5,387
|
|
|
3,085
|
|
|
Interest Rate Swaps Liability
|
|
45,404
|
|
|
133,833
|
|
|
Currency Forward Contracts
|
|
412
|
|
|
101
|
|
|
Currency Forward Contracts
|
|
219
|
|
|
395
|
|
|
$ in thousands
|
|
Three months ended March 31, 2017
|
||||||||||
|
Derivative
not designated as
hedging instrument
|
|
Realized gain (loss), net
|
|
GSE CRT embedded derivative coupon interest
|
|
Unrealized gain (loss), net
|
|
Realized and unrealized credit derivative income (loss), net
|
||||
|
GSE CRT Embedded Derivatives
|
|
—
|
|
|
5,807
|
|
|
14,148
|
|
|
19,955
|
|
|
$ in thousands
|
|
Three months ended March 31, 2016
|
||||||||||
|
Derivative
not designated as
hedging instrument
|
|
Realized gain (loss), net
|
|
GSE CRT embedded derivative coupon interest
|
|
Unrealized gain (loss), net
|
|
Realized and unrealized credit derivative income (loss), net
|
||||
|
GSE CRT Embedded Derivatives
|
|
(920
|
)
|
|
6,314
|
|
|
3,016
|
|
|
8,410
|
|
|
$ in thousands
|
|
Three months ended March 31, 2017
|
||||||||||
|
Derivative
not designated as
hedging instrument
|
|
Realized gain (loss) on derivative instruments, net
|
|
Contractual net interest expense
|
|
Unrealized gain (loss), net
|
|
Gain (loss) on derivative instruments, net
|
||||
|
Interest Rate Swaps
|
|
15,994
|
|
|
(22,894
|
)
|
|
12,950
|
|
|
6,050
|
|
|
Currency Forward Contracts
|
|
(1,076
|
)
|
|
—
|
|
|
488
|
|
|
(588
|
)
|
|
Total
|
|
14,918
|
|
|
(22,894
|
)
|
|
13,438
|
|
|
5,462
|
|
|
|
22
|
|
|
$ in thousands
|
|
Three months ended March 31, 2016
|
||||||||||
|
Derivative
not designated as hedging instrument |
|
Realized gain (loss) on derivative instruments, net
|
|
Contractual net interest expense
|
|
Unrealized gain (loss), net
|
|
Gain (loss) on derivative instruments, net
|
||||
|
Interest Rate Swaps
|
|
(43,895
|
)
|
|
(29,091
|
)
|
|
(166,671
|
)
|
|
(239,657
|
)
|
|
Interest Rate Swaptions
|
|
(1,485
|
)
|
|
—
|
|
|
1,485
|
|
|
—
|
|
|
Currency Forward Contracts
|
|
2,395
|
|
|
—
|
|
|
(1,281
|
)
|
|
1,114
|
|
|
Total
|
|
(42,985
|
)
|
|
(29,091
|
)
|
|
(166,467
|
)
|
|
(238,543
|
)
|
|
|
|
|
|
|
|
|
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
|
|
|
||||||||
|
$ in thousands
Description
|
Gross
Amounts of
Recognized
Assets
|
|
Gross
Amounts
Offset in the Condensed Consolidated
Balance
Sheets
|
|
Net Amounts
of Assets
presented in
the Condensed
Consolidated
Balance Sheets
|
|
Financial
Instruments
|
|
Cash Collateral
Received
|
|
Net Amount
|
||||||
|
Derivatives
(1) (4)
|
5,799
|
|
|
—
|
|
|
5,799
|
|
|
(219
|
)
|
|
(3,189
|
)
|
|
2,391
|
|
|
Total
|
5,799
|
|
|
—
|
|
|
5,799
|
|
|
(219
|
)
|
|
(3,189
|
)
|
|
2,391
|
|
|
|
23
|
|
|
|
|
|
|
|
|
|
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
|
|
|
||||||||
|
$ in thousands
Description
|
Gross
Amounts of
Recognized
Liabilities
|
|
Gross
Amounts
Offset in the Condensed Consolidated
Balance
Sheets
|
|
Net Amounts
of Liabilities
presented in
the Condensed
Consolidated
Balance Sheets
|
|
Financial
Instruments
(2)
|
|
Cash Collateral
Posted
|
|
Net Amount
|
||||||
|
Derivatives
(4)
|
37,829
|
|
|
—
|
|
|
37,829
|
|
|
(37,829
|
)
|
|
—
|
|
|
—
|
|
|
Repurchase Agreements
(3)
|
12,289,899
|
|
|
—
|
|
|
12,289,899
|
|
|
(12,289,899
|
)
|
|
—
|
|
|
—
|
|
|
Secured Loans
(5)
|
1,650,000
|
|
|
—
|
|
|
1,650,000
|
|
|
(1,650,000
|
)
|
|
—
|
|
|
—
|
|
|
Total
|
13,977,728
|
|
|
—
|
|
|
13,977,728
|
|
|
(13,977,728
|
)
|
|
—
|
|
|
—
|
|
|
|
|
|
|
|
|
|
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
|
|
|
||||||||
|
$ in thousands
Description
|
Gross
Amounts of
Recognized
Assets
|
|
Gross
Amounts
Offset in the Condensed Consolidated
Balance
Sheets
|
|
Net Amounts
of Assets
presented in
the Condensed
Consolidated
Balance Sheets
|
|
Financial
Instruments
|
|
Cash Collateral
Received
|
|
Net Amount
|
||||||
|
Derivatives
(1) (4)
|
3,186
|
|
|
—
|
|
|
3,186
|
|
|
(1,640
|
)
|
|
(1,546
|
)
|
|
—
|
|
|
Total
|
3,186
|
|
|
—
|
|
|
3,186
|
|
|
(1,640
|
)
|
|
(1,546
|
)
|
|
—
|
|
|
|
|
|
|
|
|
|
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets
|
|
|
||||||||
|
$ in thousands
Description
|
Gross
Amounts of
Recognized
Liabilities
|
|
Gross
Amounts
Offset in the Condensed Consolidated
Balance
Sheets
|
|
Net Amounts
of Liabilities
presented in
the Condensed
Consolidated
Balance Sheets
|
|
Financial
Instruments
(2)
|
|
Cash Collateral
Posted
|
|
Net Amount
|
||||||
|
Derivatives
(4)
|
134,228
|
|
|
—
|
|
|
134,228
|
|
|
(45,738
|
)
|
|
(85,787
|
)
|
|
2,703
|
|
|
Repurchase Agreements
(3)
|
11,160,669
|
|
|
—
|
|
|
11,160,669
|
|
|
(11,160,669
|
)
|
|
—
|
|
|
—
|
|
|
Secured Loans
(5)
|
1,650,000
|
|
|
—
|
|
|
1,650,000
|
|
|
(1,650,000
|
)
|
|
—
|
|
|
—
|
|
|
Total
|
12,944,897
|
|
|
—
|
|
|
12,944,897
|
|
|
(12,856,407
|
)
|
|
(85,787
|
)
|
|
2,703
|
|
|
(1)
|
Amounts represent derivatives in an asset position which could potentially be offset against derivatives in a liability position at
March 31, 2017
and
December 31, 2016
, subject to a netting arrangement.
|
|
(2)
|
Amounts represent collateral pledged that is available to be offset against liability balances associated with repurchase agreements, secured loans and derivatives.
|
|
(3)
|
The fair value of securities pledged against our borrowing under repurchase agreements was
$13.6 billion
and
$12.4 billion
at
March 31, 2017
and
December 31, 2016
, respectively.
|
|
(4)
|
Cash collateral received on our derivatives was
$3.7 million
and
$1.7 million
at
March 31, 2017
and
December 31, 2016
, respectively. Non-cash collateral received on our derivatives was
$837,000
and
$536,000
at
March 31, 2017
and
December 31, 2016
, respectively. Cash collateral posted by us on our derivatives was
$86.5 million
at
December 31, 2016
. As a result of the CME rule change effective January 3, 2017, cash collateral pledged on our centrally cleared
|
|
|
24
|
|
|
(5)
|
The fair value of securities pledged against IAS Services LLC's borrowing under secured loans was
$1.9 billion
at
March 31, 2017
and
December 31, 2016
, respectively.
|
|
•
|
Level 1 Inputs
– Quoted prices for identical instruments in active markets.
|
|
•
|
Level 2 Inputs
– Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.
|
|
•
|
Level 3 Inputs
– Instruments with primarily unobservable value drivers.
|
|
|
March 31, 2017
|
|
|
|||||||||||
|
|
Fair Value Measurements Using:
|
|
|
|||||||||||
|
$ in thousands
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
NAV as a practical expedient
(3)
|
|
Total at
Fair Value
|
|||||
|
Assets:
|
|
|
|
|
|
|
|
|
|
|||||
|
Mortgage-backed and credit risk transfer securities
(1)(2)
|
—
|
|
|
15,889,854
|
|
|
31,243
|
|
|
—
|
|
|
15,921,097
|
|
|
Derivative assets
|
—
|
|
|
5,799
|
|
|
—
|
|
|
—
|
|
|
5,799
|
|
|
Other assets
(4)
|
4,017
|
|
|
—
|
|
|
—
|
|
|
33,336
|
|
|
37,353
|
|
|
Total assets
|
4,017
|
|
|
15,895,653
|
|
|
31,243
|
|
|
33,336
|
|
|
15,964,249
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|||||
|
Derivative liabilities
|
—
|
|
|
45,623
|
|
|
—
|
|
|
—
|
|
|
45,623
|
|
|
Total liabilities
|
—
|
|
|
45,623
|
|
|
—
|
|
|
—
|
|
|
45,623
|
|
|
|
25
|
|
|
|
December 31, 2016
|
|
|
|||||||||||
|
|
Fair Value Measurements Using:
|
|
|
|||||||||||
|
$ in thousands
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
NAV as a practical expedient
(3)
|
|
Total at
Fair Value |
|||||
|
Assets:
|
|
|
|
|
|
|
|
|
|
|||||
|
Mortgage-backed and credit risk transfer securities
(1)(2)
|
—
|
|
|
14,964,236
|
|
|
17,095
|
|
|
—
|
|
|
14,981,331
|
|
|
Derivative assets
|
—
|
|
|
3,186
|
|
|
—
|
|
|
—
|
|
|
3,186
|
|
|
Other assets
(4)
|
500
|
|
|
—
|
|
|
—
|
|
|
33,301
|
|
|
33,801
|
|
|
Total assets
|
500
|
|
|
14,967,422
|
|
|
17,095
|
|
|
33,301
|
|
|
15,018,318
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|||||
|
Derivative liabilities
|
—
|
|
|
134,228
|
|
|
—
|
|
|
—
|
|
|
134,228
|
|
|
Total liabilities
|
—
|
|
|
134,228
|
|
|
—
|
|
|
—
|
|
|
134,228
|
|
|
(1)
|
For more detail about the fair value of our MBS and GSE CRTs, refer to Note 4 - "Mortgage-Backed and Credit Risk Transfer Securities."
|
|
(2)
|
Our GSE CRTs purchased prior to August 24, 2015 are accounted for as hybrid financial instruments with an embedded derivative. The hybrid instruments consist of debt host contracts classified as Level 2 and embedded derivatives classified as Level 3. As of
March 31, 2017
, the net embedded derivative asset position of
$31.2 million
includes
|
|
(3)
|
Investments in unconsolidated ventures are valued using the net asset value ("NAV") as a practical expedient and are not subject to redemption, although investors may sell or transfer their interest at the approval of the general partner of the underlying funds. As of
March 31, 2017
and
December 31, 2016
, the weighted average remaining term of investments in unconsolidated ventures is
1.3
and
1.3
years, respectively.
|
|
(4)
|
Includes
$4.0 million
and
$0.5 million
of investment in an exchange-traded fund as of
March 31, 2017
and
December 31, 2016
, respectively.
|
|
|
Three Months Ended
March 31, |
||||
|
$ in thousands
|
2017
|
|
2016
|
||
|
Beginning balance
|
17,095
|
|
|
(25,722
|
)
|
|
Sales and settlements
|
—
|
|
|
920
|
|
|
Total net gains / (losses) included in net income:
|
|
|
|
||
|
Realized gains/(losses), net
|
—
|
|
|
(920
|
)
|
|
Unrealized gains/(losses), net
(1)
|
14,148
|
|
|
3,016
|
|
|
Ending balance
|
31,243
|
|
|
(22,706
|
)
|
|
(1)
|
Included in realized and unrealized credit derivative income (loss), net in the condensed consolidated statements of operations are
$14.1 million
in net unrealized gains and
$2.1 million
in net unrealized gains attributable to assets still held as of
March 31, 2017
and
March 31, 2016
, respectively. During the thee months ended March 31, 2016, we reversed
$920,000
in net unrealized losses on securities sold during the period. We did not reverse any unrealized gains or losses on securities sold in the
three months ended
March 31, 2017
.
|
|
|
26
|
|
|
|
Fair Value at
|
|
Valuation
|
|
Unobservable
|
|
|
|
Weighted
|
|
|
$ in thousands
|
March 31, 2017
|
|
Technique
|
|
Input
|
|
Range
|
|
Average
|
|
|
GSE CRT Embedded Derivatives
|
31,243
|
|
|
Market Comparables, Vendor Pricing
|
|
Weighted average life
|
|
4.1 - 7.7
|
|
6.1
|
|
|
Fair Value at
|
|
Valuation
|
|
Unobservable
|
|
|
|
Weighted
|
|
|
$ in thousands
|
December 31, 2016
|
|
Technique
|
|
Input
|
|
Range
|
|
Average
|
|
|
GSE CRT Embedded Derivatives
|
17,095
|
|
|
Market Comparables, Vendor Pricing
|
|
Weighted average life
|
|
2.5 - 7.7
|
|
5.3
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||||||
|
$ in thousands
|
Carrying
Value
|
|
Estimated
Fair Value
|
|
Carrying
Value
|
|
Estimated
Fair Value
|
||||
|
Financial Assets
|
|
|
|
|
|
|
|
||||
|
Commercial loans, held-for-investment
|
275,944
|
|
|
277,340
|
|
|
273,355
|
|
|
275,319
|
|
|
Other assets
|
74,250
|
|
|
74,250
|
|
|
74,250
|
|
|
74,250
|
|
|
Total
|
350,194
|
|
|
351,590
|
|
|
347,605
|
|
|
349,569
|
|
|
Financial Liabilities
|
|
|
|
|
|
|
|
||||
|
Repurchase agreements
|
12,289,899
|
|
|
12,289,777
|
|
|
11,160,669
|
|
|
11,161,034
|
|
|
Secured loans
|
1,650,000
|
|
|
1,650,000
|
|
|
1,650,000
|
|
|
1,650,000
|
|
|
Exchangeable senior notes
|
248,530
|
|
|
252,188
|
|
|
397,041
|
|
|
400,000
|
|
|
Total
|
14,188,429
|
|
|
14,191,965
|
|
|
13,207,710
|
|
|
13,211,034
|
|
|
•
|
The estimated fair value of commercial loans held-for-investment is a Level 3 fair value measurement. Subsequent to the origination or purchase, commercial loan investments are valued on at a monthly basis by an independent third party valuation agent using a discounted cash flow technique.
|
|
•
|
The estimated fair value of FHLBI stock, included in "Other assets," is a Level 3 fair value measurement. FHLBI stock may only be sold back to the FHLBI at its discretion at cost. As a result, the cost of the FHLBI stock approximates its fair value.
|
|
•
|
The estimated fair value of repurchase agreements is a Level 3 fair value measurement based on an expected present value technique. This method discounts future estimated cash flows using rates we determined best reflect current market interest rates that would be offered for repurchase agreements with similar characteristics and credit quality.
|
|
•
|
The estimated fair value of secured loans is a Level 3 fair value measurement. The secured loans have floating rates based on an index plus a spread and the spread is typically consistent with those demanded in the market. Accordingly, the interest rates on these secured loans are at market, and thus the carrying amount approximates fair value.
|
|
•
|
The estimated fair value of exchangeable senior notes is a Level 2 fair value measurement based on a valuation obtained from a third-party pricing service.
|
|
|
27
|
|
|
|
28
|
|
|
|
March 31, 2017
|
||||||||||
|
$ in thousands
|
Equity method investments
|
|
Available-for-sale securities
|
|
Derivatives and hedging
|
|
Total
|
||||
|
Other comprehensive income/(loss), net
|
|
|
|
|
|
|
|
||||
|
Unrealized gain (loss) on mortgage-backed and credit risk transfer securities, net
|
—
|
|
|
16,289
|
|
|
—
|
|
|
16,289
|
|
|
Reclassification of unrealized (gain) loss on sale of mortgage-backed and credit risk transfer securities to gain (loss) on investments, net
|
—
|
|
|
850
|
|
|
—
|
|
|
850
|
|
|
Reclassification of amortization of net deferred (gain) loss on de-designated interest rate swaps to repurchase agreements interest expense
|
—
|
|
|
—
|
|
|
(6,298
|
)
|
|
(6,298
|
)
|
|
Currency translation adjustments on investment in unconsolidated ventures
|
(615
|
)
|
|
—
|
|
|
—
|
|
|
(615
|
)
|
|
Other comprehensive income/(loss), net
|
(615
|
)
|
|
17,139
|
|
|
(6,298
|
)
|
|
10,226
|
|
|
|
|
|
|
|
|
|
|
||||
|
Balance at beginning of period
|
95
|
|
|
144,458
|
|
|
149,115
|
|
|
293,668
|
|
|
Other comprehensive income/(loss), net
|
(615
|
)
|
|
17,139
|
|
|
(6,298
|
)
|
|
10,226
|
|
|
Other comprehensive income/(loss) attributable to non-controlling interest
|
8
|
|
|
(216
|
)
|
|
79
|
|
|
(129
|
)
|
|
Balance at end of period
|
(512
|
)
|
|
161,381
|
|
|
142,896
|
|
|
303,765
|
|
|
|
December 31, 2016
|
||||||||||
|
$ in thousands
|
Equity method investments
|
|
Available-for-sale securities
|
|
Derivatives and hedging
|
|
Total
|
||||
|
Other comprehensive income/(loss), net
|
|
|
|
|
|
|
|
||||
|
Unrealized gain (loss) on mortgage-backed and credit risk transfer securities, net
|
—
|
|
|
(37,632
|
)
|
|
—
|
|
|
(37,632
|
)
|
|
Reclassification of unrealized (gain) loss on sale of mortgage-backed and credit risk transfer securities to gain (loss) on investments, net
|
—
|
|
|
6,134
|
|
|
—
|
|
|
6,134
|
|
|
Reclassification of amortization of net deferred (gain) loss on de-designated interest rate swaps to repurchase agreements interest expense
|
—
|
|
|
—
|
|
|
5,154
|
|
|
5,154
|
|
|
Currency translation adjustments on investment in unconsolidated ventures
|
128
|
|
|
—
|
|
|
—
|
|
|
128
|
|
|
Other comprehensive income/(loss), net
|
128
|
|
|
(31,498
|
)
|
|
5,154
|
|
|
(26,216
|
)
|
|
|
|
|
|
|
|
|
|
||||
|
Balance at beginning of period
|
(32
|
)
|
|
170,383
|
|
|
148,273
|
|
|
318,624
|
|
|
Other comprehensive income/(loss), net
|
128
|
|
|
(31,498
|
)
|
|
5,154
|
|
|
(26,216
|
)
|
|
Other comprehensive income/(loss) attributable to non-controlling interest
|
(1
|
)
|
|
412
|
|
|
(63
|
)
|
|
348
|
|
|
Rebalancing of ownership percentage of non-controlling interest
|
—
|
|
|
5,161
|
|
|
(4,249
|
)
|
|
912
|
|
|
Balance at end of period
|
95
|
|
|
144,458
|
|
|
149,115
|
|
|
293,668
|
|
|
|
29
|
|
|
|
Three Months Ended March 31,
|
|||||
|
|
2017
|
|||||
|
|
Restricted Stock Units
|
|
Weighted Average Grant Date Fair Value
(1)
|
|||
|
Unvested at the beginning of the period
|
18,807
|
|
|
$
|
14.37
|
|
|
Shares granted during the period
|
8,115
|
|
|
15.55
|
|
|
|
Shares vested during the period
|
(7,095
|
)
|
|
15.78
|
|
|
|
Unvested at the end of the period
|
19,827
|
|
|
$
|
14.35
|
|
|
(1)
|
The grant date fair value of restricted stock awards is based on the closing market price of our common stock at the grant date.
|
|
|
30
|
|
|
•
|
a dividend of
$0.40
per share of common stock to be paid on
April 26, 2017
to stockholders of record as of the close of business on
March 27, 2017
;
|
|
•
|
a dividend of
$0.4844
per share of Series A Preferred Stock to be paid on
April 25, 2017
to stockholders of record as of the close of business on
April 1, 2017
; and
|
|
•
|
a dividend of
$0.4844
per share of Series B Preferred Stock to be paid on
June 27, 2017
to stockholders of record as of the close of business on
June 5, 2017
.
|
|
|
Three Months Ended
March 31, |
||||
|
$ and share amounts in thousands
|
2017
|
|
2016
|
||
|
Numerator (Income)
|
|
|
|
||
|
Basic Earnings:
|
|
|
|
||
|
Net income (loss) available to common stockholders
|
87,130
|
|
|
(156,160
|
)
|
|
Effect of dilutive securities:
|
|
|
|
||
|
Income allocated to exchangeable senior notes
|
5,008
|
|
|
—
|
|
|
Income (loss) allocated to non-controlling interest
|
1,186
|
|
|
(1,883
|
)
|
|
Dilutive net income (loss) available to stockholders
|
93,324
|
|
|
(158,043
|
)
|
|
Denominator (Weighted Average Shares)
|
|
|
|
||
|
Basic Earnings:
|
|
|
|
||
|
Shares available to common stockholders
|
111,598
|
|
|
113,142
|
|
|
Effect of dilutive securities:
|
|
|
|
||
|
Restricted stock awards
|
19
|
|
|
—
|
|
|
OP units
|
1,425
|
|
|
1,425
|
|
|
Exchangeable senior notes
|
15,083
|
|
|
—
|
|
|
Dilutive Shares
|
128,125
|
|
|
114,567
|
|
|
|
31
|
|
|
|
Three Months Ended
March 31, |
||||
|
$ in thousands
|
2017
|
|
2016
|
||
|
Net income (loss) allocated
|
1,186
|
|
|
(1,883
|
)
|
|
Distributions paid
|
570
|
|
|
570
|
|
|
|
32
|
|
|
$ in thousands
|
Three Months Ended March 31, 2016
|
|||||||
|
|
As Reported
|
|
Adjustment
|
|
As Revised
|
|||
|
Interest Income
|
|
|
|
|
|
|||
|
Mortgage-backed and credit risk transfer securities
|
121,087
|
|
|
1,159
|
|
|
122,246
|
|
|
Other Income
|
|
|
|
|
|
|||
|
Gain (loss) on investments, net
|
11,601
|
|
|
—
|
|
|
11,601
|
|
|
Net income
|
(153,486
|
)
|
|
1,159
|
|
|
(152,327
|
)
|
|
Net income attributable to non-controlling interest
|
(1,897
|
)
|
|
14
|
|
|
(1,883
|
)
|
|
Net income attributable to Invesco Mortgage Capital Inc.
|
(151,589
|
)
|
|
1,145
|
|
|
(150,444
|
)
|
|
Net income attributable to common stockholders
|
(157,305
|
)
|
|
1,145
|
|
|
(156,160
|
)
|
|
Earnings per share:
|
|
|
|
|
|
|||
|
Net income attributable to common stockholders
|
|
|
|
|
|
|||
|
Basic
|
(1.39
|
)
|
|
0.01
|
|
|
(1.38
|
)
|
|
Diluted
|
(1.39
|
)
|
|
0.01
|
|
|
(1.38
|
)
|
|
$ in thousands
|
Three Months Ended March 31, 2016
|
|||||||
|
|
As Reported
|
|
Adjustment
|
|
As Revised
|
|||
|
Net income (loss)
|
(153,486
|
)
|
|
1,159
|
|
|
(152,327
|
)
|
|
Unrealized gain (loss) on mortgage-backed and credit risk transfer securities, net
|
122,619
|
|
|
(1,159
|
)
|
|
121,460
|
|
|
Reclassification of unrealized (gain) loss on sale of mortgage-backed and credit risk transfer securities to gain (loss) on investments, net
|
(10,544
|
)
|
|
—
|
|
|
(10,544
|
)
|
|
Total other comprehensive income (loss)
|
124,950
|
|
|
(1,159
|
)
|
|
123,791
|
|
|
$ in thousands
|
Three Months Ended March 31, 2016
|
|||||||
|
|
As Reported
|
|
Adjustment
|
|
As Revised
|
|||
|
Cash Flows from Operating Activities
|
|
|
|
|
|
|||
|
Net income
|
(153,486
|
)
|
|
1,159
|
|
|
(152,327
|
)
|
|
Amortization of mortgage-backed and credit risk transfer securities premiums and (discounts), net
|
25,207
|
|
|
(1,159
|
)
|
|
24,048
|
|
|
Non-cash Investing and Financing Activities Information
|
|
|
|
|
|
|||
|
Net change in unrealized gain on mortgage-backed and credit risk transfer securities
|
112,075
|
|
|
(1,159
|
)
|
|
110,916
|
|
|
|
33
|
|
|
ITEM 2.
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
|
|
•
|
our business and investment strategy;
|
|
•
|
our investment portfolio;
|
|
•
|
our projected operating results;
|
|
•
|
general volatility of financial markets and effects of governmental responses, including actions and initiatives of the U.S. governmental agencies and changes to U.S. government policies, including the Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Dodd-Frank Act”), mortgage loan modification programs, actions and initiatives of foreign governmental agencies and central banks, monetary policy actions of the Federal Reserve, including actions relating to its agency mortgage-backed securities portfolio and the continuation of re-investment of principal payments, and our ability to respond to and comply with such actions, initiatives and changes;
|
|
•
|
the availability of financing sources, including our ability to obtain additional financing arrangements and the terms of such arrangements;
|
|
•
|
financing and advance rates for our target assets;
|
|
•
|
changes to our expected leverage;
|
|
•
|
our expected investments;
|
|
•
|
our expected book value per share of common stock;
|
|
•
|
interest rate mismatches between our target assets and our borrowings used to fund such investments;
|
|
•
|
the adequacy of our cash flow from operations and borrowings to meet our short-term liquidity needs;
|
|
•
|
our ability to maintain sufficient liquidity to meet any margin calls;
|
|
•
|
changes in the credit rating of the U.S. government;
|
|
•
|
changes in interest rates and interest rate spreads and the market value of our target assets;
|
|
•
|
changes in prepayment rates on our target assets;
|
|
•
|
the impact of any deficiencies in foreclosure practices of third parties and related uncertainty in the timing of collateral disposition;
|
|
•
|
our reliance on third parties in connection with services related to our target assets;
|
|
•
|
effects of hedging instruments on our target assets;
|
|
|
34
|
|
|
•
|
rates of default or decreased recovery rates on our target assets;
|
|
•
|
modifications to whole loans or loans underlying securities;
|
|
•
|
the degree to which our hedging strategies may or may not protect us from interest rate volatility;
|
|
•
|
the degree to which derivative contracts expose us to contingent liabilities;
|
|
•
|
counterparty defaults;
|
|
•
|
compliance with financial covenants in our financing arrangements;
|
|
•
|
changes in governmental regulations, zoning, insurance, eminent domain and tax law and rates, and similar matters and our ability to respond to such changes;
|
|
•
|
our ability to maintain our qualification as a real estate investment trust for U.S. federal income tax purposes;
|
|
•
|
our ability to maintain our exception from the definition of “investment company” under the Investment Company Act of 1940, as amended (the “1940 Act”);
|
|
•
|
availability of investment opportunities in mortgage-related, real estate-related and other securities;
|
|
•
|
availability of U.S. Government Agency guarantees with regard to payments of principal and interest on securities;
|
|
•
|
the market price and trading volume of our capital stock;
|
|
•
|
availability of qualified personnel of our Manager;
|
|
•
|
the relationship with our Manager;
|
|
•
|
estimates relating to taxable income and our ability to continue to make distributions to our stockholders in the future;
|
|
•
|
estimates relating to fair value of our target assets and loan loss reserves;
|
|
•
|
our understanding of our competition;
|
|
•
|
changes to generally accepted accounting principles in the United States of America (“U.S. GAAP”);
|
|
•
|
the adequacy of our disclosure controls and procedures and internal controls over financial reporting; and
|
|
•
|
market trends in our industry, interest rates, real estate values, the debt securities markets or the general economy.
|
|
•
|
Residential mortgage-backed securities (“RMBS”) that are guaranteed by a U.S. government agency such as the Government National Mortgage Association or a federally chartered corporation such as the Federal National Mortgage Association or the Federal Home Loan Mortgage Corporation (collectively "Agency RMBS");
|
|
•
|
RMBS that are not guaranteed by a U.S. government agency ("non-Agency RMBS");
|
|
•
|
Credit risk transfer securities that are unsecured obligations issued by government-sponsored enterprises ("GSE CRT");
|
|
|
35
|
|
|
•
|
Commercial mortgage-backed securities (“CMBS”);
|
|
•
|
Residential and commercial mortgage loans; and
|
|
•
|
Other real estate-related financing arrangements.
|
|
•
|
a dividend of
$0.40
per share of common stock to be paid on
April 26, 2017
to stockholders of record as of the close of business on
March 27, 2017
;
|
|
•
|
a dividend of
$0.4844
per share of Series A Preferred Stock to be paid on
April 25, 2017
to stockholders of record as of the close of business on
April 1, 2017
; and
|
|
•
|
a dividend of
$0.4844
per share of Series B Preferred Stock to be paid on
June 27, 2017
to stockholders of record as of the close of business on
June 5, 2017
.
|
|
|
36
|
|
|
|
As of
|
|||||||
|
$ in thousands
|
March 31, 2017
|
|
December 31, 2016
|
|
March 31, 2016
|
|||
|
Agency RMBS
|
39
|
%
|
|
41
|
%
|
|
34
|
%
|
|
Commercial Credit
(1)
|
33
|
%
|
|
32
|
%
|
|
36
|
%
|
|
Residential Credit
(2)
|
28
|
%
|
|
27
|
%
|
|
30
|
%
|
|
Total
|
100
|
%
|
|
100
|
%
|
|
100
|
%
|
|
(1)
|
CMBS, Commercial loans and Investments in unconsolidated ventures (which are included in Other Assets), are considered commercial credit.
|
|
(2)
|
Non-Agency RMBS, GSE CRT and Residential loans are considered residential credit.
|
|
|
37
|
|
|
|
As of
|
|||||||
|
$ in thousands
|
March 31, 2017
|
|
December 31, 2016
|
|
March 31, 2016
|
|||
|
Agency RMBS:
|
|
|
|
|
|
|||
|
30 year fixed-rate, at fair value
|
4,492,324
|
|
|
2,981,717
|
|
|
3,966,251
|
|
|
15 year fixed-rate, at fair value
|
3,418,231
|
|
|
3,557,928
|
|
|
1,565,165
|
|
|
Hybrid ARM, at fair value
|
2,101,319
|
|
|
2,474,301
|
|
|
3,040,726
|
|
|
ARM, at fair value
|
290,690
|
|
|
307,873
|
|
|
413,649
|
|
|
Agency CMO, at fair value
|
319,718
|
|
|
344,041
|
|
|
410,569
|
|
|
Non-Agency RMBS, at fair value
|
1,774,088
|
|
|
1,995,551
|
|
|
2,384,965
|
|
|
GSE CRT, at fair value
|
855,657
|
|
|
768,200
|
|
|
650,791
|
|
|
CMBS, at fair value
|
2,669,070
|
|
|
2,551,720
|
|
|
2,701,950
|
|
|
Commercial loans, at amortized cost
|
275,944
|
|
|
273,355
|
|
|
277,701
|
|
|
Investments in unconsolidated ventures
|
33,336
|
|
|
33,301
|
|
|
39,541
|
|
|
Total Investment portfolio
|
16,230,377
|
|
|
15,287,987
|
|
|
15,451,308
|
|
|
|
38
|
|
|
|
2003
|
|
2004
|
|
2005
|
|
2006
|
|
2007
|
|
2008
|
|
2009
|
|
2010
|
|
2011
|
|
2012
|
|
2013
|
|
2014
|
|
2015
|
|
2016
|
|
2017
|
|
Total
|
||||||||||||||||
|
Prime
|
0.5
|
%
|
|
1.6
|
%
|
|
4.4
|
%
|
|
4.0
|
%
|
|
8.6
|
%
|
|
2.5
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
13.7
|
%
|
|
11.0
|
%
|
|
1.6
|
%
|
|
0.3
|
%
|
|
—
|
%
|
|
48.2
|
%
|
|
Alt-A
|
—
|
%
|
|
0.7
|
%
|
|
8.0
|
%
|
|
6.9
|
%
|
|
8.7
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
24.3
|
%
|
|
Re-REMIC
(1)
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
0.5
|
%
|
|
—
|
%
|
|
0.7
|
%
|
|
4.6
|
%
|
|
5.9
|
%
|
|
2.5
|
%
|
|
0.8
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
15.0
|
%
|
|
Subprime/reperforming
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
0.3
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
2.9
|
%
|
|
7.2
|
%
|
|
2.1
|
%
|
|
—
|
%
|
|
—
|
%
|
|
12.5
|
%
|
|
Total Non-Agency
|
0.5
|
%
|
|
2.3
|
%
|
|
12.4
|
%
|
|
10.9
|
%
|
|
18.1
|
%
|
|
2.5
|
%
|
|
0.7
|
%
|
|
4.6
|
%
|
|
5.9
|
%
|
|
2.5
|
%
|
|
17.4
|
%
|
|
18.2
|
%
|
|
3.7
|
%
|
|
0.3
|
%
|
|
—
|
%
|
|
100.0
|
%
|
|
GSE CRT
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
31.4
|
%
|
|
36.0
|
%
|
|
8.5
|
%
|
|
20.8
|
%
|
|
3.3
|
%
|
|
100.0
|
%
|
|
CMBS
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
4.6
|
%
|
|
23.6
|
%
|
|
14.7
|
%
|
|
16.7
|
%
|
|
33.7
|
%
|
|
5.3
|
%
|
|
—
|
%
|
|
1.4
|
%
|
|
100.0
|
%
|
|
(1)
|
For Re-REMICs, the table reflects the year in which the resecuritizations were issued. The vintage distribution of the securities that collateralize our Re-REMIC investments is
9.3%
for
2005
,
15.6%
for
2006
, and
75.1%
for
2007
.
|
|
Non-Agency RMBS
State
|
|
Percentage
|
|
GSE CRT
State
|
|
Percentage
|
|
CMBS
State
|
|
Percentage
|
|||
|
California
|
|
41.8
|
%
|
|
California
|
|
19.0
|
%
|
|
California
|
|
14.8
|
%
|
|
New York
|
|
7.8
|
%
|
|
Texas
|
|
6.1
|
%
|
|
New York
|
|
13.7
|
%
|
|
Florida
|
|
6.2
|
%
|
|
Florida
|
|
4.3
|
%
|
|
Texas
|
|
10.1
|
%
|
|
Virginia
|
|
3.6
|
%
|
|
New York
|
|
4.3
|
%
|
|
Florida
|
|
6.1
|
%
|
|
New Jersey
|
|
3.4
|
%
|
|
Virginia
|
|
4.2
|
%
|
|
Pennsylvania
|
|
4.6
|
%
|
|
Maryland
|
|
3.3
|
%
|
|
Illinois
|
|
3.8
|
%
|
|
Illinois
|
|
4.2
|
%
|
|
Massachusetts
|
|
3.0
|
%
|
|
Washington
|
|
3.4
|
%
|
|
New Jersey
|
|
3.6
|
%
|
|
Illinois
|
|
2.9
|
%
|
|
Massachusetts
|
|
3.4
|
%
|
|
Ohio
|
|
3.1
|
%
|
|
Washington
|
|
2.5
|
%
|
|
New Jersey
|
|
3.2
|
%
|
|
Virginia
|
|
2.8
|
%
|
|
Texas
|
|
2.2
|
%
|
|
Colorado
|
|
3.2
|
%
|
|
Michigan
|
|
2.7
|
%
|
|
Other
|
|
23.3
|
%
|
|
Other
|
|
45.1
|
%
|
|
Other
|
|
34.3
|
%
|
|
Total
|
|
100.0
|
%
|
|
Total
|
|
100.0
|
%
|
|
Total
|
|
100.0
|
%
|
|
|
39
|
|
|
$ in thousands
|
Collateralized borrowings under repurchase agreements and secured loans
|
|||||||
|
Quarter Ended
|
Quarter-end balance
|
|
Average quarterly balance
|
|
Maximum balance of any quarter-end
|
|||
|
March 31, 2016
|
12,837,159
|
|
|
13,137,569
|
|
|
13,501,433
|
|
|
June 30, 2016
|
13,418,647
|
|
|
13,075,770
|
|
|
13,418,647
|
|
|
September 30, 2016
|
13,710,502
|
|
|
13,826,469
|
|
|
13,984,960
|
|
|
December 31, 2016
|
12,810,669
|
|
|
13,215,697
|
|
|
13,626,829
|
|
|
March 31, 2017
|
13,939,899
|
|
|
13,901,254
|
|
|
14,086,600
|
|
|
|
40
|
|
|
|
As of
|
||||
|
In thousands except per share amounts
|
March 31, 2017
|
|
December 31, 2016
|
||
|
Numerator (adjusted equity):
|
|
|
|
||
|
Total equity
|
2,323,630
|
|
|
2,270,184
|
|
|
Less: Liquidation preference of Series A Preferred Stock
|
(140,000
|
)
|
|
(140,000
|
)
|
|
Less: Liquidation preference of Series B Preferred Stock
|
(155,000
|
)
|
|
(155,000
|
)
|
|
Total adjusted equity
|
2,028,630
|
|
|
1,975,184
|
|
|
|
|
|
|
||
|
Denominator (number of shares - diluted):
|
|
|
|
||
|
Common stock outstanding
|
111,605
|
|
|
111,595
|
|
|
OP units
|
1,425
|
|
|
1,425
|
|
|
Number of shares - diluted
|
113,030
|
|
|
113,020
|
|
|
|
|
|
|
||
|
Book value per diluted common share
|
17.95
|
|
|
17.48
|
|
|
|
41
|
|
|
|
42
|
|
|
|
Three Months Ended
March 31, |
||||
|
$ in thousands, except share data
|
2017
|
|
2016
|
||
|
Interest Income
|
|
|
|
||
|
Mortgage-backed and credit risk transfer securities
|
118,873
|
|
|
122,246
|
|
|
Commercial loans
|
5,764
|
|
|
4,893
|
|
|
Total interest income
|
124,637
|
|
|
127,139
|
|
|
Interest Expense
|
|
|
|
||
|
Repurchase agreements
|
29,947
|
|
|
41,800
|
|
|
Secured loans
|
3,413
|
|
|
2,715
|
|
|
Exchangeable senior notes
|
5,008
|
|
|
5,613
|
|
|
Total interest expense
|
38,368
|
|
|
50,128
|
|
|
Net interest income
|
86,269
|
|
|
77,011
|
|
|
Other Income (loss)
|
|
|
|
||
|
Gain (loss) on investments, net
|
(1,853
|
)
|
|
11,601
|
|
|
Equity in earnings (losses) of unconsolidated ventures
|
(1,534
|
)
|
|
1,061
|
|
|
Gain (loss) on derivative instruments, net
|
5,462
|
|
|
(238,543
|
)
|
|
Realized and unrealized credit derivative income (loss), net
|
19,955
|
|
|
8,410
|
|
|
Net loss on extinguishment of debt
|
(4,711
|
)
|
|
—
|
|
|
Other investment income (loss), net
|
1,329
|
|
|
(318
|
)
|
|
Total other income (loss)
|
18,648
|
|
|
(217,789
|
)
|
|
Expenses
|
|
|
|
||
|
Management fee – related party
|
8,801
|
|
|
9,512
|
|
|
General and administrative
|
2,084
|
|
|
2,037
|
|
|
Total expenses
|
10,885
|
|
|
11,549
|
|
|
Net income (loss)
|
94,032
|
|
|
(152,327
|
)
|
|
Net income (loss) attributable to non-controlling interest
|
1,186
|
|
|
(1,883
|
)
|
|
Net income (loss) attributable to Invesco Mortgage Capital Inc.
|
92,846
|
|
|
(150,444
|
)
|
|
Dividends to preferred stockholders
|
5,716
|
|
|
5,716
|
|
|
Net income (loss) attributable to common stockholders
|
87,130
|
|
|
(156,160
|
)
|
|
Earnings (loss) per share:
|
|
|
|
||
|
Net income (loss) attributable to common stockholders
|
|
|
|
||
|
Basic
|
0.78
|
|
|
(1.38
|
)
|
|
Diluted
|
0.73
|
|
|
(1.38
|
)
|
|
Dividends declared per common share
|
0.40
|
|
|
0.40
|
|
|
Weighted average number of shares of common stock:
|
|
|
|
||
|
Basic
|
111,598,459
|
|
|
113,142,400
|
|
|
Diluted
|
128,124,628
|
|
|
114,567,400
|
|
|
|
43
|
|
|
|
Three Months Ended
March 31, |
||||
|
$ in thousands
|
2017
|
|
2016
|
||
|
Average Balances
(1)
:
|
|
|
|
||
|
Agency RMBS:
|
|
|
|
||
|
15 year fixed-rate, at amortized cost
|
3,516,699
|
|
|
1,560,925
|
|
|
30 year fixed-rate, at amortized cost
|
4,460,663
|
|
|
3,945,655
|
|
|
ARM, at amortized cost
|
290,812
|
|
|
410,749
|
|
|
Hybrid ARM, at amortized cost
|
2,291,634
|
|
|
3,096,649
|
|
|
Agency - CMO, at amortized cost
|
328,450
|
|
|
404,443
|
|
|
Non-Agency RMBS, at amortized cost
|
1,793,030
|
|
|
2,422,438
|
|
|
GSE CRT, at amortized cost
|
765,690
|
|
|
676,169
|
|
|
CMBS, at amortized cost
|
2,575,734
|
|
|
2,675,219
|
|
|
Commercial loans, at amortized cost
|
274,981
|
|
|
239,201
|
|
|
Average earning assets
|
16,297,693
|
|
|
15,431,448
|
|
|
Average Earning Asset Yields
(2)
:
|
|
|
|
||
|
Agency RMBS:
|
|
|
|
||
|
15 year fixed-rate
|
2.03
|
%
|
|
2.40
|
%
|
|
30 year fixed-rate
|
2.64
|
%
|
|
2.97
|
%
|
|
ARM
|
2.31
|
%
|
|
2.42
|
%
|
|
Hybrid ARM
|
2.29
|
%
|
|
2.28
|
%
|
|
Agency - CMO
|
0.58
|
%
|
|
2.80
|
%
|
|
Non-Agency RMBS
|
5.58
|
%
|
|
4.90
|
%
|
|
GSE CRT
(3)
|
2.15
|
%
|
|
0.85
|
%
|
|
CMBS
|
4.20
|
%
|
|
4.38
|
%
|
|
Commercial loans
|
8.50
|
%
|
|
8.09
|
%
|
|
Average earning asset yields
|
3.06
|
%
|
|
3.30
|
%
|
|
(1)
|
Average amounts for each period are based on weighted month-end balances.
|
|
(2)
|
Average earning asset yield for the period was calculated by dividing interest income, including amortization of premiums and discounts, by our average of the amortized cost of the investments. All yields are annualized.
|
|
(3)
|
GSE CRT average earning asset yield excludes coupon interest associated with embedded derivatives on securities not accounted for under the fair value option that is recorded as realized and unrealized credit derivative income (loss), net under U.S. GAAP.
|
|
|
44
|
|
|
|
Three Months Ended
March 31, |
||||
|
$ in thousands, except share amounts
|
2017
|
|
2016
|
||
|
Interest Income
|
|
|
|
||
|
MBS and GSE CRT - coupon interest
|
146,069
|
|
|
146,294
|
|
|
MBS and GSE CRT - net (premium amortization)/ discount accretion
|
(27,196
|
)
|
|
(24,048
|
)
|
|
MBS and GSE CRT - interest income
|
118,873
|
|
|
122,246
|
|
|
Commercial loans
|
5,764
|
|
|
4,893
|
|
|
Total interest income
|
124,637
|
|
|
127,139
|
|
|
|
Three Months Ended
|
||||
|
|
March 31, 2017
|
March 31, 2016
|
|||
|
15 year fixed-rate Agency RMBS
|
8.1
|
|
|
10.2
|
|
|
30 year fixed-rate Agency RMBS
|
10.8
|
|
|
10.8
|
|
|
ARM/ Hybrid ARM Agency RMBS
|
15.7
|
|
|
12.5
|
|
|
Non-Agency RMBS
|
13.3
|
|
|
11.1
|
|
|
GSE CRT
|
13.1
|
|
|
9.2
|
|
|
Weighted average CPR
|
11.7
|
|
|
11.2
|
|
|
|
45
|
|
|
|
Three Months Ended
March 31, |
||||
|
$ in thousands
|
2017
|
|
2016
|
||
|
Interest Expense
|
|
|
|
||
|
Interest expense on repurchase agreements borrowings
|
36,245
|
|
|
28,876
|
|
|
Amortization of net deferred (gain) loss on de-designated interest rate swaps
|
(6,298
|
)
|
|
12,924
|
|
|
Repurchase agreements interest expense
|
29,947
|
|
|
41,800
|
|
|
Secured loans
|
3,413
|
|
|
2,715
|
|
|
Exchangeable senior notes
|
5,008
|
|
|
5,613
|
|
|
Total interest expense
|
38,368
|
|
|
50,128
|
|
|
|
46
|
|
|
|
Three Months Ended
March 31, |
||||
|
$ in thousands
|
2017
|
|
2016
|
||
|
Average Borrowings
(1)
:
|
|
|
|
||
|
Agency RMBS
(2)
|
9,716,908
|
|
|
8,546,280
|
|
|
Non-Agency RMBS
|
1,411,889
|
|
|
1,952,569
|
|
|
GSE CRT
|
600,223
|
|
|
451,248
|
|
|
CMBS
(2)
|
2,172,234
|
|
|
2,187,472
|
|
|
Exchangeable senior notes
|
346,083
|
|
|
394,982
|
|
|
Total average borrowings
|
14,247,337
|
|
|
13,532,551
|
|
|
Maximum borrowings during the period
(3)
|
14,484,038
|
|
|
13,896,215
|
|
|
Average Cost of Funds
(4)
:
|
|
|
|
||
|
Agency RMBS
(2)
|
0.87
|
%
|
|
0.66
|
%
|
|
Non-Agency RMBS
|
2.20
|
%
|
|
1.80
|
%
|
|
GSE CRT
|
2.27
|
%
|
|
2.19
|
%
|
|
CMBS
(2)
|
1.34
|
%
|
|
1.14
|
%
|
|
Exchangeable senior notes
|
5.79
|
%
|
|
5.68
|
%
|
|
Cost of funds
|
1.08
|
%
|
|
1.48
|
%
|
|
Effective cost of funds (non-GAAP measure)
(5)
|
1.90
|
%
|
|
1.96
|
%
|
|
(1)
|
Average amounts for each period are based on weighted month-end balances.
|
|
(2)
|
Agency RMBS and CMBS average borrowings and average cost of funds include borrowings under repurchase agreements and secured loans.
|
|
(3)
|
Amount represents the maximum borrowings at month-end during each of the respective periods.
|
|
(4)
|
Average cost of funds is calculated by dividing annualized interest expense excluding amortization of net deferred gain (loss) on de-designated interest rate swaps by our average borrowings.
|
|
(5)
|
For a reconciliation of cost of funds to effective cost of funds, see "Non-GAAP Financial Measures"
|
|
|
Three Months Ended
March 31, |
||||
|
$ in thousands
|
2017
|
|
2016
|
||
|
Interest Income
|
|
|
|
||
|
Mortgage-backed and credit risk transfer securities
|
118,873
|
|
|
122,246
|
|
|
Commercial loans
|
5,764
|
|
|
4,893
|
|
|
Total interest income
|
124,637
|
|
|
127,139
|
|
|
Interest Expense
|
|
|
|
||
|
Interest expense on repurchase agreements borrowings
|
36,245
|
|
|
28,876
|
|
|
Amortization of net deferred (gain) loss on de-designated interest rate swaps
|
(6,298
|
)
|
|
12,924
|
|
|
Repurchase agreements interest expense
|
29,947
|
|
|
41,800
|
|
|
Secured loans
|
3,413
|
|
|
2,715
|
|
|
Exchangeable senior notes
|
5,008
|
|
|
5,613
|
|
|
Total interest expense
|
38,368
|
|
|
50,128
|
|
|
Net interest income
|
86,269
|
|
|
77,011
|
|
|
|
47
|
|
|
$ in thousands
|
Three Months
ended March 31, 2017 |
|
Three Months
ended March 31, 2016 |
||
|
Realized gains and losses on sale of investments
|
(1,007
|
)
|
|
10,544
|
|
|
Other-than-temporary impairment losses
|
(532
|
)
|
|
(5,683
|
)
|
|
Net unrealized gains and losses on MBS accounted for under the fair value option
|
(3,602
|
)
|
|
6,676
|
|
|
Net unrealized gains and losses on GSE CRT accounted for under the fair value option
|
3,279
|
|
|
64
|
|
|
Net unrealized gains and losses on trading securities
|
9
|
|
|
—
|
|
|
Total gain (loss) on investments, net
|
(1,853
|
)
|
|
11,601
|
|
|
|
48
|
|
|
$ in thousands
|
|
Three Months Ended March 31, 2017
|
||||||||||
|
Derivative
not designated as hedging instrument |
|
Realized gain (loss) on derivative instruments, net
|
|
Contractual net interest expense
|
|
Unrealized gain (loss), net
|
|
Gain (loss) on derivative instruments, net
|
||||
|
Interest Rate Swaps
|
|
15,994
|
|
|
(22,894
|
)
|
|
12,950
|
|
|
6,050
|
|
|
Currency Forward Contracts
|
|
(1,076
|
)
|
|
—
|
|
|
488
|
|
|
(588
|
)
|
|
Total
|
|
14,918
|
|
|
(22,894
|
)
|
|
13,438
|
|
|
5,462
|
|
|
$ in thousands
|
|
Three Months Ended March 31, 2016
|
||||||||||
|
Derivative
not designated as hedging instrument |
|
Realized gain (loss) on derivative instruments, net
|
|
Contractual net interest expense
|
|
Unrealized gain (loss), net
|
|
Gain (loss) on derivative instruments, net
|
||||
|
Interest Rate Swaps
|
|
(43,895
|
)
|
|
(29,091
|
)
|
|
(166,671
|
)
|
|
(239,657
|
)
|
|
Interest Rate Swaptions
|
|
(1,485
|
)
|
|
—
|
|
|
1,485
|
|
|
—
|
|
|
Currency Forward Contracts
|
|
2,395
|
|
|
—
|
|
|
(1,281
|
)
|
|
1,114
|
|
|
Total
|
|
(42,985
|
)
|
|
(29,091
|
)
|
|
(166,467
|
)
|
|
(238,543
|
)
|
|
$ in thousands
|
|
As of March 31, 2017
|
|
As of December 31, 2016
|
||||||||||||||||||
|
Derivative instrument
|
|
Notional Amounts
(1)
|
|
Average Fixed Pay Rate
|
|
Average Receive Rate
|
|
Average Maturity (Years)
|
|
Notional Amounts
|
|
Average Fixed Pay Rate
|
|
Average Receive Rate
|
|
Average Maturity (Years)
|
||||||
|
Interest Rate Swaps
|
|
7,400,000
|
|
|
2.14
|
%
|
|
0.99
|
%
|
|
4.69
|
|
6,500,000
|
|
|
2.14
|
%
|
|
0.79
|
%
|
|
4.64
|
|
(1)
|
Excludes
$250.0 million
of notional amount for an interest rate swap with a forward start date of
5/24/2018
.
|
|
|
Three Months Ended March 31,
|
||||
|
$ in thousands
|
2017
|
|
2016
|
||
|
GSE CRT embedded derivative coupon interest
|
5,807
|
|
|
6,314
|
|
|
Gain (loss) on settlement of GSE CRT embedded derivatives
|
—
|
|
|
(920
|
)
|
|
Change in fair value of GSE CRT embedded derivatives
|
14,148
|
|
|
3,016
|
|
|
Total
|
19,955
|
|
|
8,410
|
|
|
|
49
|
|
|
|
Three Months Ended March 31,
|
||||
|
$ in thousands
|
2017
|
|
2016
|
||
|
Dividend income
|
816
|
|
|
807
|
|
|
Gain (loss) on foreign currency transactions, net
|
513
|
|
|
(1,125
|
)
|
|
Total
|
1,329
|
|
|
(318
|
)
|
|
|
50
|
|
|
|
Three Months Ended
March 31, |
||||
|
$ in thousands, except per share data
|
2017
|
|
2016
|
||
|
Net income (loss) attributable to common stockholders
|
87,130
|
|
|
(156,160
|
)
|
|
Adjustments:
|
|
|
|
||
|
(Gain) loss on investments, net
|
1,853
|
|
|
(11,601
|
)
|
|
Realized (gain) loss on derivative instruments, net
(1)
|
(14,918
|
)
|
|
42,985
|
|
|
Unrealized (gain) loss on derivative instruments, net
(1)
|
(13,438
|
)
|
|
166,467
|
|
|
Realized and unrealized (gain) loss on GSE CRT embedded derivatives, net
(2)
|
(14,148
|
)
|
|
(2,096
|
)
|
|
(Gain) loss on foreign currency transactions, net
(3)
|
(513
|
)
|
|
1,125
|
|
|
Amortization of net deferred (gain) loss on de-designated interest rate swaps
(4)
|
(6,298
|
)
|
|
12,924
|
|
|
Net loss on extinguishment of debt
|
4,711
|
|
|
—
|
|
|
Subtotal
|
(42,751
|
)
|
|
209,804
|
|
|
Cumulative adjustments attributable to non-controlling interest
|
539
|
|
|
(2,597
|
)
|
|
Core earnings attributable to common stockholders
|
44,918
|
|
|
51,047
|
|
|
Basic income (loss) per common share
|
0.78
|
|
|
(1.38
|
)
|
|
Core earnings per share attributable to common stockholders
(5)
|
0.40
|
|
|
0.45
|
|
|
|
51
|
|
|
(1)
|
U.S. GAAP gain (loss) on derivative instruments, net on the condensed consolidated statements of operations includes the following components:
|
|
|
Three Months Ended
March 31, |
||||
|
$ in thousands
|
2017
|
|
2016
|
||
|
Realized gain (loss) on derivative instruments, net
|
14,918
|
|
|
(42,985
|
)
|
|
Unrealized gain (loss) on derivative instruments, net
|
13,438
|
|
|
(166,467
|
)
|
|
Contractual net interest expense
|
(22,894
|
)
|
|
(29,091
|
)
|
|
Gain (loss) on derivative instruments, net
|
5,462
|
|
|
(238,543
|
)
|
|
(2)
|
U.S. GAAP realized and unrealized credit derivative income (loss), net on the condensed consolidated statements of operations includes the following components:
|
|
|
Three Months Ended
March 31, |
||||
|
$ in thousands
|
2017
|
|
2016
|
||
|
Realized and unrealized gain (loss) on GSE CRT embedded derivatives, net
|
14,148
|
|
|
2,096
|
|
|
GSE CRT embedded derivative coupon interest
|
5,807
|
|
|
6,314
|
|
|
Realized and unrealized credit derivative income (loss), net
|
19,955
|
|
|
8,410
|
|
|
(3)
|
U.S. GAAP other investment income (loss) net on the condensed consolidated statements of operations includes the following components:
|
|
|
Three Months Ended
March 31, |
||||
|
$ in thousands
|
2017
|
|
2016
|
||
|
Dividend income
|
816
|
|
|
807
|
|
|
Gain (loss) on foreign currency transactions, net
|
513
|
|
|
(1,125
|
)
|
|
Other investment income (loss), net
|
1,329
|
|
|
(318
|
)
|
|
(4)
|
U.S. GAAP repurchase agreements interest expense on the condensed consolidated statements of operations includes the following components:
|
|
|
Three Months Ended
March 31, |
||||
|
$ in thousands
|
2017
|
|
2016
|
||
|
Interest expense on repurchase agreements borrowings
|
36,245
|
|
|
28,876
|
|
|
Amortization of net deferred (gain) loss on de-designated interest rate swaps
|
(6,298
|
)
|
|
12,924
|
|
|
Repurchase agreements interest expense
|
29,947
|
|
|
41,800
|
|
|
(5)
|
Core earnings per share attributable to common stockholders is equal to core earnings divided by the basic weighted average number of common shares outstanding.
|
|
|
52
|
|
|
|
Three Months Ended March 31,
|
||||||||||
|
|
2017
|
|
2016
|
||||||||
|
$ in thousands
|
Reconciliation
|
|
Yield/Effective Yield
|
|
Reconciliation
|
|
Yield/Effective Yield
|
||||
|
Total interest income
|
124,637
|
|
|
3.06
|
%
|
|
127,139
|
|
|
3.30
|
%
|
|
Add: GSE CRT embedded derivative coupon interest recorded as realized and unrealized credit derivative income (loss), net
|
5,807
|
|
|
0.14
|
%
|
|
6,314
|
|
|
0.16
|
%
|
|
Effective interest income
|
130,444
|
|
|
3.20
|
%
|
|
133,453
|
|
|
3.46
|
%
|
|
|
53
|
|
|
|
Three Months Ended March 31,
|
||||||||||
|
|
2017
|
|
2016
|
||||||||
|
$ in thousands
|
Reconciliation
|
|
Cost of Funds / Effective Cost of Funds
|
|
Reconciliation
|
|
Cost of Funds / Effective Cost of Funds
|
||||
|
Total interest expense
|
38,368
|
|
|
1.08
|
%
|
|
50,128
|
|
|
1.48
|
%
|
|
Add (Less): Amortization of net deferred gain (loss) on de-designated interest rate swaps
|
6,298
|
|
|
0.18
|
%
|
|
(12,924
|
)
|
|
(0.38
|
)%
|
|
Add: Contractual net interest expense on interest rate swaps recorded as gain (loss) on derivative instruments, net
|
22,894
|
|
|
0.64
|
%
|
|
29,091
|
|
|
0.86
|
%
|
|
Effective interest expense
|
67,560
|
|
|
1.90
|
%
|
|
66,295
|
|
|
1.96
|
%
|
|
|
Three Months Ended March 31,
|
||||||||||
|
|
2017
|
|
2016
|
||||||||
|
$ in thousands
|
Reconciliation
|
|
Net Interest Rate Margin / Effective Interest Rate Margin
|
|
Reconciliation
|
|
Net Interest Rate Margin / Effective Interest Rate Margin
|
||||
|
Net interest income
|
86,269
|
|
|
1.98
|
%
|
|
77,011
|
|
|
1.82
|
%
|
|
Add (Less): Amortization of net deferred (gain) loss on de-designated interest rate swaps
|
(6,298
|
)
|
|
(0.18
|
)%
|
|
12,924
|
|
|
0.38
|
%
|
|
Add: GSE CRT embedded derivative coupon interest recorded as realized and unrealized credit derivative income (loss), net
|
5,807
|
|
|
0.14
|
%
|
|
6,314
|
|
|
0.16
|
%
|
|
Less: Contractual net interest expense on interest rate swaps recorded as gain (loss) on derivative instruments, net
|
(22,894
|
)
|
|
(0.64
|
)%
|
|
(29,091
|
)
|
|
(0.86
|
)%
|
|
Effective net interest income
|
62,884
|
|
|
1.30
|
%
|
|
67,158
|
|
|
1.50
|
%
|
|
|
54
|
|
|
$ in thousands
|
Agency
RMBS
|
Residential Credit
(1)
|
Commercial Credit
(2)
|
Exchangeable Senior Notes and Other
|
Total
|
|||||
|
Investments
|
10,622,281
|
|
2,629,745
|
|
2,978,351
|
|
—
|
|
16,230,377
|
|
|
Cash and cash equivalents
(3)
|
25,239
|
|
17,432
|
|
13,206
|
|
—
|
|
55,877
|
|
|
Derivative assets, at fair value
(4)
|
5,387
|
|
—
|
|
412
|
|
—
|
|
5,799
|
|
|
Other assets
|
340,271
|
|
6,718
|
|
64,227
|
|
4,018
|
|
415,234
|
|
|
Total assets
|
10,993,178
|
|
2,653,895
|
|
3,056,196
|
|
4,018
|
|
16,707,287
|
|
|
|
|
|
|
|
|
|||||
|
Repurchase agreements
|
9,335,954
|
|
1,921,535
|
|
1,032,410
|
|
—
|
|
12,289,899
|
|
|
Secured loans
(5)
|
497,703
|
|
—
|
|
1,152,297
|
|
—
|
|
1,650,000
|
|
|
Exchangeable senior notes
|
—
|
|
—
|
|
—
|
|
248,530
|
|
248,530
|
|
|
Derivative liabilities, at fair value
|
45,404
|
|
—
|
|
219
|
|
—
|
|
45,623
|
|
|
Other liabilities
|
111,243
|
|
22,029
|
|
15,777
|
|
556
|
|
149,605
|
|
|
Total liabilities
|
9,990,304
|
|
1,943,564
|
|
2,200,703
|
|
249,086
|
|
14,383,657
|
|
|
|
|
|
|
|
|
|||||
|
Total equity (allocated)
|
1,002,874
|
|
710,331
|
|
855,493
|
|
(245,068
|
)
|
2,323,630
|
|
|
Adjustments to calculate repurchase agreement debt-to-equity ratio:
|
|
|
|
|
|
|||||
|
Net equity in unsecured assets and exchangeable senior notes
(6)
|
—
|
|
—
|
|
(309,506
|
)
|
245,068
|
|
(64,438
|
)
|
|
Collateral pledged against secured loans
|
(578,249
|
)
|
—
|
|
(1,338,780
|
)
|
—
|
|
(1,917,029
|
)
|
|
Secured loans
|
497,703
|
|
—
|
|
1,152,297
|
|
—
|
|
1,650,000
|
|
|
Equity related to repurchase agreement debt
|
922,328
|
|
710,331
|
|
359,504
|
|
—
|
|
1,992,163
|
|
|
Debt-to-equity ratio
(7)
|
9.8
|
|
2.7
|
|
2.6
|
|
NA
|
|
6.1
|
|
|
Repurchase agreement debt-to-equity ratio
(8)
|
10.1
|
|
2.7
|
|
2.9
|
|
NA
|
|
6.2
|
|
|
(1)
|
Investments in non-Agency RMBS and GSE CRT are included in residential credit.
|
|
(2)
|
Investments in CMBS, commercial loans and investments in unconsolidated joint ventures are included in commercial credit.
|
|
(3)
|
Cash and cash equivalents is allocated based on a percentage of equity for Agency RMBS, residential credit and commercial credit.
|
|
(4)
|
Derivative assets are allocated based on the hedging strategy for each class.
|
|
(5)
|
Secured loans are allocated based on amount of collateral pledged.
|
|
(6)
|
Net equity in unsecured assets and exchangeable senior notes includes commercial loans, investments in unconsolidated joint ventures, exchangeable senior notes and other.
|
|
(7)
|
Debt-to-equity ratio is calculated as the ratio of total debt (sum of repurchase agreements, secured loans and exchangeable senior notes) to total equity.
|
|
(8)
|
Repurchase agreement debt-to-equity ratio is calculated as the ratio of repurchase agreements to equity related to repurchase agreement debt.
|
|
|
55
|
|
|
$ in thousands
|
Agency
RMBS |
Residential Credit
(1)
|
Commercial Credit
(2)
|
Exchangeable Senior Notes and Other
|
Total
|
|||||
|
Investments
|
9,665,860
|
|
2,763,751
|
|
2,858,376
|
|
—
|
|
15,287,987
|
|
|
Cash and cash equivalents
(3)
|
76,067
|
|
49,582
|
|
36,139
|
|
—
|
|
161,788
|
|
|
Derivative assets, at fair value
(4)
|
3,085
|
|
—
|
|
101
|
|
—
|
|
3,186
|
|
|
Other assets
|
179,931
|
|
9,381
|
|
63,465
|
|
500
|
|
253,277
|
|
|
Total assets
|
9,924,943
|
|
2,822,714
|
|
2,958,081
|
|
500
|
|
15,706,238
|
|
|
|
|
|
|
|
|
|||||
|
Repurchase agreements
|
8,148,220
|
|
2,067,731
|
|
944,718
|
|
—
|
|
11,160,669
|
|
|
Secured loans
(5)
|
500,150
|
|
—
|
|
1,149,850
|
|
—
|
|
1,650,000
|
|
|
Exchangeable senior notes
|
—
|
|
—
|
|
—
|
|
397,041
|
|
397,041
|
|
|
Derivative liabilities, at fair value
|
133,832
|
|
—
|
|
396
|
|
—
|
|
134,228
|
|
|
Other liabilities
|
52,047
|
|
21,389
|
|
14,791
|
|
5,889
|
|
94,116
|
|
|
Total liabilities
|
8,834,249
|
|
2,089,120
|
|
2,109,755
|
|
402,930
|
|
13,436,054
|
|
|
|
|
|
|
|
|
|||||
|
Total equity (allocated)
|
1,090,694
|
|
733,594
|
|
848,326
|
|
(402,430
|
)
|
2,270,184
|
|
|
Adjustments to calculate repurchase agreement debt-to-equity ratio:
|
|
|
|
|
|
|||||
|
Net equity in unsecured assets and exchangeable senior notes
(6)
|
—
|
|
—
|
|
(306,656
|
)
|
402,430
|
|
95,774
|
|
|
Collateral pledged against secured loans
|
(585,504
|
)
|
—
|
|
(1,346,078
|
)
|
—
|
|
(1,931,582
|
)
|
|
Secured loans
|
500,150
|
|
—
|
|
1,149,850
|
|
—
|
|
1,650,000
|
|
|
Equity related to repurchase agreement debt
|
1,005,340
|
|
733,594
|
|
345,442
|
|
—
|
|
2,084,376
|
|
|
Debt-to-equity ratio
(7)
|
7.9
|
|
2.8
|
|
2.5
|
|
NA
|
|
5.8
|
|
|
Repurchase agreement debt-to-equity ratio
(8)
|
8.1
|
|
2.8
|
|
2.7
|
|
NA
|
|
5.4
|
|
|
(1)
|
Investments in non-Agency RMBS and GSE CRT are included in residential credit.
|
|
(2)
|
Investments in CMBS, commercial loans and investments in unconsolidated joint ventures are included in commercial credit.
|
|
(3)
|
Cash and cash equivalents is allocated based on a percentage of equity for Agency RMBS, residential credit and commercial credit.
|
|
(4)
|
Derivative assets are allocated based on the hedging strategy for each class.
|
|
(5)
|
Secured loans are allocated based on amount of collateral pledged.
|
|
(6)
|
Net equity in unsecured assets and exchangeable senior notes includes commercial loans, investments in unconsolidated joint ventures, exchangeable senior notes and other.
|
|
(7)
|
Debt-to-equity ratio is calculated as the ratio of total debt (sum of repurchase agreements, secured loans and exchangeable senior notes) to total equity.
|
|
(8)
|
Repurchase agreement debt-to-equity ratio is calculated as the ratio of repurchase agreements to equity related to repurchase agreement debt.
|
|
|
56
|
|
|
|
57
|
|
|
|
58
|
|
|
|
Payments Due by Period
|
|||||||||||||
|
$ in thousands
|
Total
|
|
Less than 1
year
|
|
1-3 years
|
|
3-5 years
|
|
After 5
years
|
|||||
|
Repurchase agreements
|
12,289,899
|
|
|
12,289,899
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Secured loans
|
1,650,000
|
|
|
—
|
|
|
300,000
|
|
|
100,000
|
|
|
1,250,000
|
|
|
Exchangeable senior notes
|
250,000
|
|
|
250,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Total
(1)
|
14,189,899
|
|
|
12,539,899
|
|
|
300,000
|
|
|
100,000
|
|
|
1,250,000
|
|
|
(1)
|
Excluded from total contractual obligations are the amounts due to our Manager under the management agreement, as those obligations do not have fixed and determinable payments.
|
|
|
Three Months Ended March 31,
|
|||||
|
|
2017
|
|||||
|
|
Restricted Stock Units
|
|
Weighted Average Grant Date Fair Value
(1)
|
|||
|
Unvested at the beginning of the period
|
18,807
|
|
|
$
|
14.37
|
|
|
Shares granted during the period
|
8,115
|
|
|
15.55
|
|
|
|
Shares vested during the period
|
(7,095
|
)
|
|
15.78
|
|
|
|
Unvested at the end of the period
|
19,827
|
|
|
$
|
14.35
|
|
|
(1)
|
The grant date fair value of restricted stock awards is based on the closing market price of our common stock at the grant date.
|
|
|
59
|
|
|
|
60
|
|
|
ITEM 3.
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
|
|
|
61
|
|
|
Change in Interest Rates
|
|
Percentage Change in Projected
Net Interest Income
|
|
Percentage Change in Projected
Portfolio Value
|
||
|
+1.00%
|
|
(22.62
|
)%
|
|
(1.58
|
)%
|
|
+0.50%
|
|
(7.83
|
)%
|
|
(0.63
|
)%
|
|
-0.50%
|
|
3.58
|
%
|
|
0.72
|
%
|
|
-1.00%
|
|
(2.66
|
)%
|
|
0.94
|
%
|
|
|
62
|
|
|
•
|
monitoring and adjusting, if necessary, the reset index and interest rate related to our target assets and our financings;
|
|
•
|
attempting to structure our financing agreements to have a range of different maturities, terms, amortizations and interest rate adjustment periods;
|
|
•
|
using hedging instruments, primarily interest rate swap agreements but also financial futures, options, interest rate cap agreements, floors and forward sales to adjust the interest rate sensitivity of our target assets and our borrowings; and
|
|
•
|
actively managing, on an aggregate basis, the interest rate indices, interest rate adjustment periods, and gross reset margins of our target assets and the interest rate indices and adjustment periods of our financings.
|
|
|
63
|
|
|
ITEM 4.
|
CONTROLS AND PROCEDURES.
|
|
|
64
|
|
|
ITEM 1.
|
LEGAL PROCEEDINGS.
|
|
ITEM 1A.
|
RISK FACTORS.
|
|
ITEM 2.
|
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
|
|
ITEM 3.
|
DEFAULTS UPON SENIOR SECURITIES.
|
|
ITEM 4.
|
MINE SAFETY DISCLOSURES.
|
|
ITEM 5.
|
OTHER INFORMATION.
|
|
ITEM 6.
|
EXHIBITS.
|
|
|
65
|
|
|
|
INVESCO MORTGAGE CAPITAL INC.
|
|
|
|
|
|
|
May 4, 2017
|
By:
|
/s/ John M. Anzalone
|
|
|
|
John M. Anzalone
|
|
|
|
Chief Executive Officer
|
|
|
|
|
|
May 4, 2017
|
By:
|
/s/ Richard Lee Phegley, Jr.
|
|
|
|
Richard Lee Phegley, Jr.
|
|
|
|
Chief Financial Officer
|
|
|
66
|
|
|
Exhibit
No.
|
|
Description
|
|
|
|
|
||
|
3.1
|
|
|
Articles of Amendment and Restatement of Invesco Mortgage Capital Inc. (incorporated by reference to Exhibit 3.1 to our Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on August 12, 2009).
|
|
|
|
||
|
3.2
|
|
|
Articles Supplementary of 7.75% Series A Cumulative Redeemable Preferred Stock (incorporated by reference to Exhibit 3.3 to the Registrant’s Registration Statement on Form 8-A, filed with the SEC on July 23, 2012).
|
|
|
|
||
|
3.3
|
|
|
Articles Supplementary of 7.75% Fixed-to-Floating Series B Cumulative Redeemable Preferred Stock (incorporated by reference to Exhibit 3.3 to the Registrant’s Registration Statement on Form 8-A, filed with the SEC on September 8, 2014).
|
|
|
|
||
|
3.4
|
|
|
Amended and Restated Bylaws of Invesco Mortgage Capital Inc. (incorporated by reference to Exhibit 3.2 to Amendment No. 8 to our Registration Statement on Form S-11 (No. 333-151665), filed with the Securities and Exchange Commission on June 18, 2009).
|
|
|
|
|
|
|
31.1
|
|
|
Certification of John M. Anzalone pursuant to Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
||
|
31.2
|
|
|
Certification of Richard Lee Phegley, Jr. pursuant to Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
||
|
32.1
|
|
|
Certification of John M. Anzalone pursuant to Rule 13a-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
||
|
32.2
|
|
|
Certification of Richard Lee Phegley, Jr. pursuant to Rule 13a-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
||
|
101
|
|
|
The following series of unaudited XBRL-formatted documents are collectively included herewith as Exhibit 101. The financial information is extracted from Invesco Mortgage Capital Inc.’s unaudited condensed consolidated interim financial statements and notes that are included in this Form 10-Q Report.
101.INS XBRL Instance Document
101.SCH XBRL Taxonomy Extension Schema Document
101.CAL XBRL Taxonomy Calculation Linkbase Document
101.LAB XBRL Taxonomy Label Linkbase Document
101.PRE XBRL Taxonomy Presentation Linkbase Document
101.DEF XBRL Taxonomy Definition Linkbase Document
|
|
|
67
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|